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Actinomycin D is a cyclic-polypeptide-containing anti-
biotic which has become an important tool in molecular and 
cellular biology because of its binding to deoxyribonucleic 
acid (DNA) and subsequent inhibition of ribonucleic acid 
(RNA) synthesisd As a result, a great amount of research has 
been directed towards el.ucidating the chemical and physical 
nature of its biological activity. Even though actinomycin D 
is highly toxic, this compound has been used in nontoxic 
dosages because of its antineoplastic effect. Actinomycin D 
has been proven to be a highly effective chemotherapeutic 
agent in the treatment of Wilms' tumor, trophoblastic tumors, 
rhabdomyosarcoma and testicular cancers (Heienhofer, 1970). 
The name actinomycin was originated by Waksman, who 
discovered this group of antibiotics in cultures of Actino-
. mx:ees antibioticus in 1940. Less than 10 years elapsed before 
the structure of the actinomycins began to be revealed by the 
investigations of Dagliesh et al. (1949), Brockman et al. 
(1949) and Dagliesh et al. (1950). Actinomycin D was charac-
terized by Waksman (1954) as a brick red, crystalline sub-
stance that melted at approximately 250 C and absorbed light 
strongly at 230, 250 and 450 nm. Waksman observed that 
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actinomycin D was highly active against Gram-positive 
bacteria, less active against Gram-negative bacteria and 
almost totally ineffective against fungi. l1anaker et al. 
(1955) crystallized actinomycin D from cultures of Strepto-
tnyce!3 E,arvullus. The molecular weight was determined to be 
1255 daltons and the molecular formula was deduced as 
C60H76015N12'3 H20. 
The actinomycins were recognized very early to contain 
2 
a chromophore, which absorbed visible light, and a peptide 
linked to the chromophore. The actinomycin chromophore was 
isolated and assigned the structure, 3-amino-1,8-dimethyl-2-
phenoxazone-4,5-dicarboxylic acid, Of interest is the fact 
that this same 2-amino•3-phenoxazone ring system is found in 
the ornmochrome insect eye pigments and in several pigmented 
mold metabolites: Next, it was determined that attached to 
the two carboxyl groups of the chromophore were two penta-
peptides, whose sequences were determined by various partial 
hydrolyses. 
Isoactinomycin is used to describe an actinomycin with 
the same two pentapeptide residues, while those with different 
pentapeptides are referred to as anisoactinomycins. L-Threo-
nine is always the amino acid linked by amide bonds to the 
1- and 9-carboxyls of the chromophore and whose hydroxyl 
group always forms a lactone bond with the carboxyl of the 
fifth amino acid. The second amino acid can be either D-
valine or D-allo-isoleucine. The third can be L-proline, 
L-3-hydroxyproline, L-3-ketoproline, pipecolic acid or 
3 
sarcosine. The fourth is always sarcosine and the fifth can 
be either L-N~methylvaline or L-N-methylisoleucine. Inter-
estingly, the peptide groups contain free NH groups only in 
the two threonine residues since all other amino groups are 
methylated or contained in the ring of an imino acid. In 
addition, the second amino acid, valine or allo-isoleucine, 
has the D configuration. Actinomycin D is an isoactinomycin 
which contains the amino acids L-threonine, D-valine, L-pro-
line, sarcosine and L-N-methylvaline (Figure 1). 
Although the antimicrobial and antineoplastic activities 
of actinomycin D were recognized relatively soon after its 
discovery, it was the early 1960's before its complexation 
with DNA (Kersten et al., 1960; Kirk, 1960) and subsequent 
inhibition of RNA synthesis (Goldberg et al., 1962) became 
known. Actinomycin D binds tightly to double helical DNA, 
but poorly, if at all, to double helical RNA, RNA-DNA hybrids, 
or single stranded forms of DNA or RNA (Kaselkorn, 1964; 
Gellert et al., 1965). The complexation of actinomycin D 
with DNA has been studied using a variety of methods including 
spectrophotometric methods, buoyant density measurements, 
equilibrium dialysis, circular dichroism, optical rotatory 
dispersion, melting temperature and inhibition of DNA tem-
plate controlled P~A synthesis. DNA controlled DNA synthesis 
can also be inhibited when much larger concentrations of 
actinomycin D are utilized, However, the mechanism appears 
to be quite different. Inhibition of RNA synthesis is a 
direct consequence of steric interference by the actinomycin 
Figure 1. Structure of Actinomycin D. The funct·ional 
groups of the antibiotic are the free chromo-
phore amino group, the unreduced quinoidal ring 
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D, while inhibition of DNA synthesis appears to be inhibited 
by stabilization of the DNA (Reich, 1964). Actinomycin D 
also interferes with reactions in which DNA is modified, such 
as methylation (Gold and Hurwitz, 1964)o 
Reich and Goldberg (1964) observed that complexation of 
actinomycin D with DNA required a double stranded helix con-
taining guanine residueso Wells and Larson (1970) showed 
that the number of nucleotide pairs per bound actinomycin D 
molecule differs from 0 at 0% dG (deoxyguanosine) content to 
about 6 at 50% dG in poly-d(G-C). A relative constant number 
of binding sites was reported for DNA containing between 
25-50% G+C. This suggests the possible involvement of more 
than one base pair. Furthermore, in crab poly-d(A-T)·poly-
d(T-A) containing 97% A+T base pairs and 3% G+C base pairs, 
the number of sites available for binding was only 60% of the 
predicted value (Hyman and Davidson, 1971). This agreed with 
earlier studies by Cavalier and Nerrichin (1964) who suggested 
that there were two types of binding sites on calf thymus 
and Escherichia coli DNA for actinomycin D, one of which has 
a binding constant about 50 times greater than the other. 
The distinction between the sites was thought to depend upon 
the helical structure of the DNA. Hyman and Davidson (1970) 
noted that actinomycin D binds to the "strong binding" sites 
on T7 DNA when the actinomycin D concentration is below 
1o-5M. Above this concentration, more actinomycin D is bound 
at other weaker binding sites. 
Goldberg et al. (1962) discovered that the C(Z)-NHz 
7 
group of dG was essential for actinomycin binding. However, 
there are two exceptions to the dG specificity. The presence 
of dG is not required for binding in the case of single 
stranded poly-dl, The unique conformation of this polymer 
is thought to be responsible for its ability to bind actino-
mycin D (Wells and Larson; 1970). Conversely, in the case 
of poly-d(A-T-C)·poly-d(G-A-T), Wells and Larson observed 
that actinomycin D did not bind to this polymer although dG 
was present. This may also be due to conformation,. or the 
requirement by actinomycin D for a specific base sequence 
not found in this polynucleotideo It was also demonstrated 
in this investigation that actinomycin D would bind more 
tightly to a polydeoxyribonucleotide that contains both 
purines and pyrimidines on both strands than to a polydeoxy-
ribonucleotide containing all purines or pyrimidines on 
complementary strands. 
Krugh and Young (1977) reported that either daunomycin 
or adriamycin cooperatively facilitates the binding of acti-
nomycin D to poly-d(A-T)·poly-d(A-T) as evidenced by circular 
dichroism. Normally, actinomycin D does not bind to this 
double stranded polynucleotide. Daunomycin and adriamycin 
intercalate into double stranded DNA, but in contrast to 
actinomycin D binding, neither of these compounds show any 
requirement for a particular base at the intercalation site. 
The results of this investigation demonstrated that when 
daunomycin or adriamycin bind to poly-d(A-T)·poly-d(A-T), 
a change occurs in the conformation of the polynucleotide 
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at an adjacent region of the double helix which results in 
an increase in the stability of the actinomycin D:poly-d(A-T)· 
poly-d(A-T) complex. The transmission of the distortions 
along the double helix may also be an important component in 
the selective recognition of nucleic acid sequenc~so 
Since 1963, three models have been proposed for the 
complexation of actinomycin D and DNA. The earliest model 
by Hamilton et aL (1963) was an outside binding model in 
which the actinomycin D binds in the minor groove of DNA. 
The model involves hydrogen bonding between the actinomycin 
D C(3)=0 and the C(2)-NH2 group of guanine, the actinomycin 
D C(2)-NH2 and the guanine C(3)-N, and the actinomycin D 
C(2)-NH2 and the deoxyribose ring oxygen. The pentapeptides 
provide stabilization for the complex by forming four addi-
tional bonds between their four NH groups and the phosphodi-
ester oxygens. This type of complex would occupy the minor 
, groove over three nucleotide pairs. 
A second model by Muller and Crothers (1968) involves 
the intercalation of the actinomycin D chromophore between 
two successive base pairs with the pentapeptides projecting 
into the minor groove. One of these base pairs is G-C. The 
proposed complex is stabilized by the ele~tronic interaction 
of the chromophore 1r complex, hydrogen bonding between the 
actinomycin D carboxamide NH and the deoxyribose ring oxygen, 
and the interaction of the pentapeptide rings with each strand 
of the DNA in the minor groove. 
The third and most recent model (Figure 2) by Sobell 
Figure 2. Schematic Representation of Sobell's Model of the 
DNA:Actinomycin D Complex. The circles repre-
sent the pentapeptide rings of actinomycin D. 





(1973) combines the guanine· C(2) -NH2 group specificity of the 
outside binding model with the intercalative features of the 
second model. In this model, which is based on the crystal-
line dGz:actinomycin D complex, the phenoxazone chromophore 
intercalates between adjacent G-C pairs when the guanine 
residues are on opposite strandso This model.is stabilized 
by hydrogen bonds between the C(2)-NHz groups of guanine and 
the threonine C=O of the peptide rings which lie in the minor 
groove (trans with respect to the plane of the chromophore). 
Further stabilization results from hydrogen bonding between 
neighboring cyclic pentapeptide chains connecting the N-H of 
one D-valine residue with the carbonyl oxygen of the other 
D-valine residue. 
A unique feature of Sobell's model is the presence of 
2-fold symmetry in the actinomycin chromophore, as would be 
viewed on either side of a vector connecting the 0 and N 
bridging atoms of the phenoxazone ring. Although the symme-
try is not exact because of the C(2)-NH2 and the C(3)=0 
groups. the pentapeptide chains would closely approximate 
. 
this non-crystallographic 2-fold symmetry. The conformations 
of the peptide linkages would be: L-threonine:D-valine, 
trans; D-valine:L-proline, cis; L-proline:sarcosine, cis; 
sarcosine:L-methylvaline, trans; L-threonine:carboxamide 
carbonyl oxygen and carbon of the chromophore, trans. There-
fore, the DNA:actinomycin D complex, as described, would 
closely mimic the dGz:actinomycin D crystalline complex 
(Jain and Sobell; 1972). Sobell's model predicts that 
actinomycin D shoula bind most efficiently to poly-d(G-C)· 
poly-d(G-C) which contains alternating GpC sequences while 
other sequences would bind actinomycin D less effectively. 
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·This model also explains most of the binding data pertaining 
to actinomycin D and DNA. In addition; Sobell states that 
the binding of actinomycin D demonstrates a general principle 
that several classes of proteins may utilize in recognizing 
symmetrically arranged nucleotide sequences on the DNA helix. 
The binding of actinomycin D to DNA and its specificity in 
inhibiting the RNA polymerase reaction suggests a primitive 
repressor-operator character for this complex. If a repressor 
molecule has identical subunits related by 2-fold symmetry 
when it binds to DNA, in which the 2-fold axis coincides with 
the dyad axis of the DNA, then the base sequence in the 
operator must also have 2-fold symmetry. 
In view of this currently accepted mechanism for acti-
nomycin D binding, the potency of this compound results from 
a high degree of specificity requiring a precise and unique 
steric fit between the DNA and actinomycin D. Any modifica-
tion of this sensitive geometry of the binding complex by 
introducing changes in either actinomycin D or the DNA will 
present different parameters to the mechanism. Although the 
activities of natural occurring actinomycins differ very 
little, changes in the different portions of the synthetic 
actinomycins may alter their respective activities to varying 
degreeso Several components of the actinomycin D molecule 
have been found to be indispensable for biological activity. 
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The unreduced quinoidal phenoxazone ring system, the unaltered 
C(2)-NH2 and C(3);:::Q groups, and the intact pentapeptide lac-
tone rings are all significant, For example, the replacement 
of the two pentapeptides by the monocyclic peptide system of 
gramicidin S results in a molecule that does not bind to DNA 
or inhibit RNA synthesis (Mauger and Wade, 1966). Also, 
substitution of the C(2)-NHz group on the phenoxazone with a 
hydroxyl-, chloro- or dimethylene amino group inhibits the 
binding of actinomycin D to DNA (Reich et al.-, 1962; Huller 
and Crothers; 1968), 
As a consequence of its binding to DNA; actinomycin D 
inhibits RNA chain elongation but not template site selection, 
RNA chain initiation or RNA chain termination. Kinetic stu-
dies performed by Hyman and Davidson (1970) have shown that 
actinomycin D inhibits the rates for the incorporation of 
CTP and GTP but not of ATP and UTP. 
Three investigators i Weiss (1960), Hurwitz et al. (1960) 
and Stevens (1960), are credited with independently disco-
vering a DNA dependent enzyme which was capable of forming 
a RNA polymer from ribonucleoside 5'-triphosphates which is 
complementary to the DNA template. Weiss isolated his enzyme 
from rat liver nuclei while Hurwitz and Stevens used cell 
free extracts of E. coli. 
RNA polymerase, as defined by Burgess (1971), cannot 
only efficiently synthesize RNA but can also specifically 
initiate this synthesis on intact DNA templates. Bacterial 
RNA polymerase contains the following polypeptide subunits: 
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one beta prime; one beta, two alpha and one sigma. The 
enzyme is complete or holoenzyme when it has this makeupo 
Direct evidence that the major polypeptide components of the 
RNA polymerase holoenzyme are functional subunits is available 
for only the beta and sigma subunits. The holoenzyme can be 
separated into two functional parts: a core enzyme, consist-
ing of the two alpha, the beta and the beta prime subunits, 
which is able to synthesize RNA but lacks the ability to 
initiate such synthesis with the same specificity as the 
intact holoenzyme; and a sigma factor which acts to allow 
the efficient initiation of RNA synthesis at a specific site. 
The sigma factor is responsible for the accurate and effi-
cient ~nitiation of RNA chains at specific sites on the DNA 
template and is not required after initiation has been com-
pleted. It is not known how the sigma factor functions in 
determining specificity of binding and facilitating initia-
tion. The core enzyme is able to synthesize RNA and thus 
contains the catalytic siteo However, the interactions of 
the separate subunits within the core are not fully under-
stood. 
The holoenzyme from E. coli RNA polymerase is the most 
widely studied RNA polymerase system among bacteriao Other 
bacterial fu~A polymerases are closely related in structure 
to the E. coli holoenzymea The subunits of other Gram-
negative bacteria resemble the E. coli enzyme, although the 
molecular weight values for the sigma and alpha subunits are 
slightly higher. 
15 
The RNA polymerase reaction has the following four re-
quirements. All four ribonucleoside 5'-triphosphates (ATP, 
UTP,GTP and CTP) are required simultaneously as substrates. 
The reaction requires a divalent metal ion. Magnesium or a 
5:1 mixture of magnesium and manganese is usually employed. 
A te~plate is required for the reaction since the nature of 
the template determines the substrate requirementsG Usually, 
double stranded DNA is used although double stranded poly-
nucleotides and single stranded DNA may be used. Hhen the 
previous conditions are met; the ru~A polymerase acts to add 
mononucleotide units to the hydroxyl end of the ~~A chain 
with the elimination of pyrophosphateo As a result, the 
direction of ru~A chain growth is 5' to 3'. 
DNA directed synthesis of RNA by RNA polymerase may be 
separated into four steps (Burgess, 1971): 
1. Template site selection and activation - The RNA 
polymerase holoenzyme attaches to the DNA template, 
locates a specific site at which RNA chain initiation 
can occur, and assumes an active conformation. 
2, RNA chain initiation - The enzyme catalyzes the 
coupling of a purine ribonucleoside 5'-triphosphate 
to eliminate inorganic pyrophosphate and generate 
a diribonucleoside tetraphosphate which remains 
tightly bound to the ~~A polymeraseo 
3. RNA chain elongation - Successive ribonucleoside 
monophosphate residues are added from the substrate 
ribonucleoside 5'-triphosphates to the initial 
16 
dinucleoside tetraphosphate at its 3' hydroxyl ter-
minus to elongate th<?. nascent RNA chaino 
4. RNA chain te~mination and enzyme release - The newly 
formed RNA chain and the RNA polymerase are released 
from the template 
A variety of ccmpounds, utiU zing a multiplicity of 
mechanisms, have been employed to block or inhibit the first 
three steps of the RNA polymerase reactiono Distamycin Ar 
netropsin; pluramycin; anthramycin and phleomycin block tem-
plate site selection by binding to the DNA to hinder. RNA 
polymerase binding. Heparin and sodium polyethylene sulpho-
nate bind to the Rl\l'A polymerase to prevent this same step. 
RNA ch~in initiation can be blocked by proflavine sulfate or 
kanchanomycin which bind to the DNA to interfere with initia-
tion while streptovaricin; sodium polyethylene sulphonate; 
rifamycin derivatives and streptolydigin bind to the RNA 
polymerase to interfere with this step. Cordycepin 5'-tri-
phosphate binds to the RNA chain to block RNA chain elonga-
tion. In addition to actinomycin D, several compounds 
including ethidium bromide, nogalomycin; daunomycin, adria-
mycin; echinomycin, olivomycin and hedamycin also bind to 
the DNA to inhibit RNA chain elongation. Streptolydigin inhi-
bits RNA chain elongation by binding to the RNA polymerase. 
Most attempts to potentiate actinomycin D action have 
been directed at creating permeability changes in the cell 
which ultimately allow actinomycin D to diffuse more readily 
through the permeability barrier. The decreased sensitivity 
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of the'Gram-negative microorganisms is largely due to their 
outer membrane ultrastructure which was believed to possess 
an exclusion limit of about 600 daltons, as had previously 
been reported for the enterics. However, recent investiga-
tions by Hancock et al. (1979) have demonstrated that this 
value is not ubiquitous for all Gram-negatives·since they 
observed that the exclusion limit of Pseudomonas aeruginosa 
is in the order of 6000 + 3000 daltons. It was concluded 
that a single major outer membrane polypeptide, with an appar-
ent molecular weight of 35,000 daltons; provides a hydrophilic 
pore which is responsible for the size-dependent permeability 
of the outer membrane in this bacterium. Similar proteins 
serve in this same role in the enterics. 
Several different agents have been utilized to potentiate 
the action of actinomycin D by altering the permeability bar-
rier of the cell such that entry of actinomycin D into the 
cell is increased. Leive (1965) reported that treatment of 
E. ·coli with EDTA increased susceptibility to actinomycin D 
and that lipopolysaccharide was released from the cell wall. 
Roy and l .. fitra (1970) were also able to release lipopolysac-
charide by infecting E. coli K-12 cell with the small fila-
mentous phage, Hl3, Consequently, an increase in actinomycin 
D inhibition was observed. The nonionic detergent, Tween 80, 
was successfully used in combination with actinomycin D and 
daunomycin to significantly increase the sensitivity of nor-
mally resistant Chinese hamster cells to these antibiotics 
(Riehm and Bieldler, 1972). This effect was observed at less 
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than toxic concentrations of Tween 80. A study by Marks 
and Venditti (1976) demonstrated the ability of DNA to poten-
tiate the activity of actinomycin D with a concomitant 
negation of the cytotoxicity which accompanies treatment by 
this antibiotic, 
Efforts have also been directed at alleviating inhibi-
tion resulting from actinomycin D. Foley (1956) noted the 
ability of pantothenate to compete with and reverse actino-
mycin D inhibition of growth~ Reversal of actinomycin D 
inhibition of Neurospo~a crassa with £-aminobenzoic acid, 
tyrosine and phenylalanine was reported by Rauen and Hess 
(1959)~ The ability of B-vitamins, amino acids of caesin 
hydrolysate, purines, pyrimidines pnd nucleotides to prevent 
growth inhibition of Bacillus subtilis by actinomycin D was 
tested by Slotnick (1960). Addition of actinomycin D im-
mediately inhibited protein and RNA synthesis but not DNA 
synthesis. In several organisms having an exogenous require-
ment for pantothenate, the inhibition of actinomycin D was 
competitively altered by the presence of pantothenate. How-
ever, efforts to restore balanced RNA and protein synthesis 
to the system pro,Jed unsuccessful. Kersten (1961) observed 
that deoxyguanosine and DNA could counteract growth inhibition 
of ~· crassa and Streptococcus faecalis by actinomycin Do 
Prevention of the inhibition of protein synthesis by actino-
mycin D in Sarcoma-37 ascites cells was accomplished by adding 
glucose to the medium (Honig and Rabinovitz, 1965). 
Previous investigation in this laboratory has 
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demonstrated the capacity of selected compounds to modify the 
biological activity of actinomycin D. Durham et al. (1974) 
reported that noninhibitory concentrations of a hydroxypyra-
zole (Figure 3), iO,ll-dihydro ... 3H-napth(1,2g)indazol-7-ol, 
abets the inhibition of actinomycin D when the two were used 
in combination. A very pronounced increase in inhibition was 
observed with Pseudomonas fluorescens while a similar but 
lessened activity was noted with other microorganisms and 
L-M tissue culture cells. Conversely, Durham and Keudell 
(1969) ·observed that low concentrations. of 3.4-dihydroxy-
benzoic acid (protocatechuate) (Figure 4) prevented or re-
versed the inhibition by. actinomycin D of cell viability, 
uracil-z-14c incorporation and leucine-z-14c incorporation 
when Po fluorescens was the test organism. It was also noted 
that protocatechuate did not c.ompete with or otherwise in-
fluence the uptake mechanism of 14c-actinomycin D. 
These data suggested that molecular complexation of the 
hydroxypyrazole or protocatechuate with actinomycin D may be 
an important facet of their respective mechanisms. Durham 
and Ferguson (1971) reported that the inhibition of the syn-
thesis of amidase (acylamide amidohydrolase, EC 3.5ol.4) in 
P. fluorescens by actinomycin D could be prevented or reversed 
by protocatechuateo A number of selected benzoic acid deri-
vatives were tested that influenced actinomycin D inhibition. 
The results revealed that the steric specificity and confor-
mational integrity of the molecule were very important. The 
adjacent dihydroxyl structure, in addition to the occupation 
Figure 3. Structure of 10,11-dihydro-3H-napth(l,2 g) 
indazol-7-ol. The molecule has both polar and 
non-polar properties. The aromatic rings con-
stitute the non-polar portion of the molecule 
while the hydroxyl group and the nitrogens 
contribute polar properties to the molecule. 
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Figure 4$ Structure of Protocatechuate (3,4-dihydroxybenzoic 
acid). The two hydroxyl groups and the carboxyl 
group which are attached to the aromatic ring 






of the 3-position on the benzene ring; appears to be critical 
for the interaction of protocatechuate with actinomycin D. 
Molecular models depict that the benzenoid compounds may 
align themselves along the horizontal plane of the unreduced 
quinoidal phenoxazone ring structure of the actinomycin D. 
In this arrangenent 1 a type of complex may be formed between 
the compounds in \vhich there is 'IT (orbital) overlap along 
with H-bonding so that a complex of the two molecules forms. 
These data suggested that the protocatechuate has a greater 
affinity than DNA for actinomycin D. Therefore, a complex 
between protocatechuate and actinomycin D may produce an 
equilibrium which no longer favors the interaction of the 
actinomycin D with the DNA. 
Considerable evidence from UV-fluorescence- UV-absorp-
tion, DNA thermal denaturation and calorimetry studies have 
provided support for a complex between actinomycin D and the 
hydroxypyrazole (Haslam; 1973). Additional evidence for 
complexation between these two compounds was provided by 
lH NMR analysis in DzO (Chestnut et al., 1974), and a later 
lH NMR and l3c NMR analysis in n3coD (O'Donnell et al., 1978). 
Of importance, is that all NMR data from these two investiga-
tions suggested that a molecular complex was formed between 
actinomycin D and the hydroxypyrazole regardless of the con-
centrations or solvents used. Furthermore, the preferred 
arrangement in both models was a 1:1 stacked arrangement 
rather than side by side (Figure 5), even though the proposed 
orientations of the two compounds were not identical. 
Figure 5. Proposed Orientation of the Hydroxypyrazole:Acti-
nomycin D Complex in DzO (A Complex) and in 





Blunk (1977) reported that the inhibition of the synthe-
sis of the amidase enzyme of P. fluorescens by actinomycin D 
could also be increased when the hydroxypyrazole was added 
in combination. It was also demonstrated in this study that 
protocatechuate could prevent or reverse the inhibition of 
enzyme synthesis resulting from the combination of these two 
compounds, DNA thermal denaturation studies yielded that all 
three compounds individually interact with the DNA to stabi-
lize the DNA helix and shift the melting curve to higher 
temperatures. The combination of all three compounds almost 
completely stabilized the DNA until the melting temperature 
was elevated to 85 C. Equilibrium dialysis experiments illus-
trated that the combination of all three compounds was dia-
lyzed from the DNA more quickly than the combination of 
actinomycin D and the hydroxypyrazole. From these data, it 
was concluded that protocatechuate may be interacting with 
actinomycin D and the hydroxypyrazole to form a three-way 
complex which does not interact as favorably with DNA as the 
proposed actinomycin D and hydroxypyrazole complex. 
The hydroxypyrazole used in this investigation was syn-
thesized by Dr. K . .0. Berlin and Dr; J. G. Horgan at Oklahoma 
State University (Morgan et al., 1971). This compound has a 
molecular weight of 236 daltons, a melting point of 257-.260 C 
and ultraviolet absorption peaks of 258, 266, 300 and 312 nm. 
The benzene rings of the hydroxypyrazole constitute a large 
nonpolar nucleus with the hydroxyl and the two nitrogen groups 
contributing polar properties to the molecule. B. subtilis, 
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a Gram-positive bacterium, was readily inhibited by the bac-
teriostatic action of the hydroxypyrazole while the Gram-
negative bacterium, P. fluorescens, remained unaffectedo 
Haslam (1973) utilized both sheep red blood cells and B. 
subtilis W23 protoplasts to demonstrate that the hydroxy-
pyrazole exhibited only very subtle action against the mem-
brane. Experiments were also conducted to determine if the 
hydroxypyrazole could increase the antibacterial action of 
selected antibiotics against P. fluorescens. Hith the ex-
ception of actinomycin D, only the two membrane active anti-
biotics, polymyxin and circulin, exhibited an increase in 
inhibition when used in .combination with the hydroxypyrazole. 
No increase in the activity of vancomycin, penicillin, chlo-
ramphenicol, 5-fluorouracil or mitomycin C was demonstrated. 
It is the purpose of this. investigation to relate the 
possible mechanism(s) by which the hydroxypyrazole and proto-
catechuate influence actinomycin D action in selected in 
vitro model systems to those effects which are observed in 
P. fluorescens. Elucidation of these mechanisms will be use-
ful for optimizing the antimicrobial and antitumor applica-
tions of actinomycin D. P. fluorescens provides a useful 
model system for determining the response of Gram-negative 
bacteria to these compounds because this bacterium is resis-
tant to all but higher concentrations of most antibiotics 
and requires only an organic carbon source plus minimal salts 
for growth. Although actinomycin D is a potent antitumor 
agent, clinical usage has been severely limited by its 
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extreme toxicity, Compounds which increase actinomycin D 
action without contributing to its toxicity may allow smaller 
dosages of the antitumor agent to be given without decreasing 
its antitumor activityo Conversely, compounds which negate 
actinomycin D action may allow larger dosages of actinomycin 
D to be given because subsequential treatment with the appro-
priate compound may enhance recovery of normal cells and the 
immune system .. Furthermore, if actinomycin D action can be 
affected by complexation with selected compounds, actinomycin 
D may be more efficiently utilized clinicallyo An under-
standing of molecular complexes formed between actinomycin D 
and compounds which modulate its biological activity would 
be invaluable for designing and synthesizing analogs of 
actinomycin D which may be more effective chemotherapeutic 
agents than the parent compound. 
CHAPTER II 
MATERIALS AND METHODS 
Test Organism 
The microorganism used during the course of these studies 
was a strain of Pseudomonas obtained from the stock culture 
collection of Dr. N. N. Durham, Oklahoma State University. 
The organism was identified by Montgomery (1966) as Pseudo-
monas fluor.escens. Stock cultures were maintained on 0.2% 
succinate-salts agar slants and stored at 4 C. 
Deionize;d Water 
Deionized water was obtained from a Barnstead Nanopure 
water system (model number D 1798) consisting of an organic 
removal cartridge, followed by two mixed resin deionization 
cartridges and one submicron filter. Water with an 18 meg-
ohm-em resistance was used to make all solutions except 
growth medium. Growth medium was made with distilled water 
which was passed through a Barnstead high capacity deioniza-
tion column (model number D 8901). 
Glassware Preparation 
All glassware used in the RNA polymerase, DNA, amidase 
and vesicle investigations was cleaned with RBS 35 concentrate 
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(Pierce) before extensive rinsing with hot tap water followed 
by three rinses of deionized water from the Barnstead Nano-
pure water system. The glassware was then heat treated at 
250 C for 3 hours to eliminate ribonuclease, deoxyribonuclease 
and protease contamination. Glassware utilized for phosphate 
determination was cleaned in a sulfuric acid:dichromate solu-
tion consisting of 125 g of sodium dichromate, 1000 ml of 
tap water and 1600 ml of concentrated sulfuric acid. All 
other glassware was cleaned with Alconox (Scientific Products) 
followed by extensive rinsing with hot tap water and three 
rinses with distilled deionized water from the Barnstead high 
capacity deionization column. 
Media 
The synthetic salts medium used in this investigation 
had the following composition: 0.2% sodium chloride, 0.2% 
ammonium chloride, 0.32% potassium dihydrogen phosphate, 
0.42% dipotassium hydrogen phosphate and 0.2% succinate. The 
pH of the medium was adjusted to 6.8-7.0 with potassium hy-
droxide pellets prior to autoclaving at 121 C with 15 pounds 
pressure per square inch for 15 minutes. After cooling to 
room temperature, Ool ml of a sterile mineral salts solution 
was added to each 100 ml of medium. The mineral salts solu-
tion contained 5.0% magnesium sulfate, 0.1% manganese sulfate, 
1.0% ferric chloride and 0.5% calcium chloride in distilled 
deionized watero This solution had been sterilized by auto-
claving as described,. and was used after the suspension was 
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allowed to settle (Durham, 1958). Agar (Difco) was added to 
give a final concentration of 2o0% when a solid medium was 
requiredo Acetamide was used as the inducer of amidase en-
zyme synthesis by adding acetamide to yield a final concen-
tration of 0.08 M. The term mineral salts buffer was used 
to designate the basal salts medium in the absence of a car-
bon sourceo 
Growth of Cells 
Erlenmeyer flasks (250 ml) containing 50 ml of medium 
were inoculated from a freshly grown stock culture of P. lli-
orescens and incubated at 37 C on a reciprocal shaker (100 
oscillations per minute). The cells were harvested by cen-
trifugation (5000 x g for 10 minutes) and washed twice with 
minimal salts buffer. Sterile tubes (18 x 150 mm) containing 
growth medium and the appropria.te compounds to be tested were 
inoculated with the washed cell suspension to give a final 
volume of 5o0 ml. Tube dilution assays were followed by 
measuring the increase in absorbency of the cultures at 540 
nm on a BCiusch and Lomb Spectronic 70 spectrophotometer. 
Amidase assays were performed in side-arm flasks (250 ml) 
containing a total volume of 25 ml. Larger quantities of 
cells were often needed for various isolations. These cells 
were grown in Fernbach flasks (2800 ml) containing 500 ml 
of growth medium. 
33 
Chemicals 
Actinomycin D was generously supplied by the Merck, 
Sharp and Dohme Research Laboratoryo The hydroxypyrazole was 
provided byDro K. D$ Berlin, Oklahoma State Universityo 
Stock solutions of these two compounds were prepared in ster-
ile deionized water and stored at 4 C in the darko Stock 
solutions of protocatechuate (Aldrich Chemical Coo, Inc.) 
were prepared and filter sterilized inrrnediately prior to 
usage. All radioactive compounds were purchased from the 
Amersham Corporation and stored at -20 C in the dark. All 
other chemicals used in this investigation were of the highest 
purity available. 
Amidase Enzyme Induction 
Cultures of P. fluorescens were allowed to grow for 9 
hours in succinate medium. At this time, the cells were 
harvested by centrifugation (5000 x g for 10 minutes) and 
washed twice with minimal salts buffer. The pellet was re-
suspended in minimal salts buffer and used to inoculate the 
growth medium containing succinate, acetamide and the com-
pounds of interesto Sidearm flasks (250 ml) containing a 
total volume of 25 ml were inoculated to give an initial 
absorbance of 0.20 at 540 nm. Samples (0.25 ml) were re-
moved from the flasks at the desired time intervals and im-
mediately frozen at -20 C for later determination of enzyme 
activity. At this same time, a A540 nm reading was taken so 
that dry weight could be calculated. 
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Amidase Assay Method 
The assay used in determining amidase enzyme synthesis 
was based on the ability of acyl phosphates to react with 
hydroxylamine at pH 6.5· to 7.0 to form hydroxamic acids 
(Lipmann and Tuttle, 1945)o Quantitation of hydroxamic acid 
which reacts with ferric salts to produce red to violet co-
lored complexes, was easily accomplished with a spectropho-
tometer. 
Preparation of the Standard Curve 
A stock solution of hydroxamic acid was pre.pared by 
dissolving 0 0 5 g of succinic anhydride in 20 ml of freshly 
neutralized 2.0 M hydroxylamine hydrochloride. After allow-
ing the solution to stand for 10 minutes, deionized water 
was added to give a final volume of 50 ml. A 1:40 dilution 
of this stock solution with deionized water was used to pro-
duce the standard solution. Two ml of the standard solution 
was mixed with 1.0 ml of freshly neutralized hydroxylamine 
hydrochlorideo After standing for 10 minutes, 2.0 ml of 
ferric chloride (6% w/v in 2% v/v hydrochloric acid) was 
added and the absorbance read in a Bausch and Lomb Spectronic 
70 at 540 nm. The absorbance from this solution was equiva-
lent to 4 0 0 micromoles of acetohydroxamic acido Dilutions 
of the stock solution were prepared in a total volume of 40 
ml to give the desired concentrations of acetohydroxamateo 
A standard curve for acetohydroxamate was plotted from the 
absorbencies of the different solutions. 
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Amidase As;tiyity 
The Brammer and Clarke (1964) modification of the Lip-
mann and Tuttle (1945) method for hydroxamic acid determin-
ation was used in this investigationo This modification 
utilizes the quantitation of acetohydroxamate which is one 
of the products of the translocase reaction catalyzed by the 
amidase enzyme. The amidase catalyzes the transfer of the 
acyl group of the substrate amides to hydroxylamine to form 
acylhydroxamates (Kelly and Kornberg, 1962). The nature of 
this reaction is described below. 
CH3-co-NH2 + NH2-0H -------.:.-> CH3~cO-NH-OH + NH3 
The frozen samples were thawed and 0.75 ml of a sub-
strate mixture containing equal volumes of 0.4 M acetamide, 
freshly neutralized 2. 0 J1 hydroxylamine hydrochloride and 
0.1 M 2-amino-2-(hydroxymethyl)-1-3-proanediol (Tris-HCl) 
buffer (pH 7.2) was added. The tubes containing the reaction 
mixture were incubated at 37 C for 15 minutes. Termination 
of the reaction was achieved by.the addition of 2.0 ml of 
ferric chloride (6% w/v in 2% v/v hydrochloric acid). A red 
to violet color appears immediately and the absorbance at 
540 nm was determined using a Bausch and Lomb Spectronic 70. 
The amount of acetohydroxamate was calculated from the ace-
tohydroxamate standard curve. Specific activity was calcu-
lated by defining one unit of amidase as the amount of enzyme 
that would produce one micromole of acetohydroxamate per mg 
dry cell weight per 15 minutes. 
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Isolation and Purification of Amidase 
Growth of P. fluorescens 
Aliquots (25 ml) from a liquid culture which had been 
incubated for 9 hours on a reciprocal shaker were used to 
inoculate 6 Fernbach flasks (2800 ml) containing 475 ml of 
medium. These flasks were incubated for.9 hours before har-
vesting. At this time, the cells were in the late log phase 
of growth and had a cell density between Oa400 and 0,425 mg 
dry weight per ml. The cells were harvested and washed twice 
with minimal salts buffer by centrifugation at 4 C and 5000 
x g for 10 minutes. The yield was between 25-30 g wet weight. 
Harvested cells were stored as a thick paste at -20 C without 
any significant loss of amidase activity. 
Preparation of Ultrasonic Extracts 
The method of Kelly and Kor.nberg (1964) was used to iso-
late and purify the amidase enzyme. Approximately 15 g of 
cells (wet weight) were suspended at 4 C in 200 ml of 0.5 M 
potassium phosphate buffer (pH 7.2). Twenty ml ~ortions were 
exposed for 90 seconds (30 second bursts) to the output of 
a Branson Model S75 sonifier operating at 8.0 A~ The sus-
pensions of broken cells were combined and centrifuged at 
4 C and 15,000 x g for 15 minuteso The supernatant was de-
canted and retained. The sediment was suspended in 200 ml 
of 0.2 M potassium phosphate buffer (pH 7.2) and the ultra-
sonic treatment and centrifugation procedures were repeated. 
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The supernatant from this treatment was combined with the 
initial supernatant. One or two crystals of bovine pancreas 
deoxyribonuclease I was added to the combined supernatants 
before allowing the suspension to incubate at 25 C forlS 
minuteso 
Heat Treatment 
The combined supernatant solutions were divided between 
2 thin-walled flasks (500 ml) and both flasks were incubated 
in a water bath at 60 C for 10 minuteso Then the flasks 
were rapidly cooled in an i:ce-water bath for 5 minutes. All 
subsequent operations were performed at 4.C. The 2 batches 
were combined and centrifuged at 4. C and 25,000 x g for 1 
hour. The supernatant was decanted and the sediment was re-
suspended in 50 ml of 0.1 M potassium phosphate buffer (pH 
7.2) and centrifuged at 4 C and 25,000 x g for 1 hour. 
Ammonium Sulfate Precipitation 
The supernatant solutions were combined and the bulk 
of their protein content precipitated by the addition of 
ammonium sulfate at a concentration of 300 g per 450 ml of 
supernatant to give 90% (w/v) saturation. After standing for 
30 minutes; the precipitate was collected by centrifugation 
at 4 C and 25;000 x g for 15 minutes. The precipitate was 
dissolved in a minimum volume of the initial column buffer 
(pH 7.2) consisting of 5 w1 potassium phosphate, 1 mM diso-
dium ethylenediaminetetraacetate (EDTA) and 1 mM cysteine. 
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This mixture was placed in dialysis tubing having an exclu-
sion limit of 12,000 daltons and dialyzed against 4 changes 
of 2 liters of this buffer for 12 hours. 
Column ChroruatograE.bz 
DEAE-cellulose (Sigma Chemical Company, fine mesh-0.89 
meq/g) was prepared by suspending 10-20 g of the cellulose 
in 500 ml of the initial column.buffer contained in a 1000 
ml beakero This mixture was allowed to settle for 15 minutes 
before decanting and discarding the supernatant. An addi-
tional 400 ml of buffer was added to the DEAE-cellulose, 
stirred gently and allowed to settle for 15 minutes. This 
process was repeated until the supernatant no longer became 
cloudy. After the final washing, the DEAE-cellulose was 
resuspended in a small amount of the buffer and adjusted to 
pH 7.2 with phosphoric acid. A 2x20 em column was poured 
and packed by washing with 2 lit~rs of the initial column 
buffer at a flow rate of 40 ml per hour. The dialyzed pro-
tein was applied to the column at the rate of 15 ml per hour . 
. 
The loaded column was developed with the initial column buf-
fer and subsequently with a linear phosphate gradiento A 
Pharmacia gradient mixer was used to form the gradient by 
allowing 300 ml of 0.4 M potassium phosphate buffer (pH 7.2) 
containing 1 mH EDTA and 1 mH cysteine to flow with constant 
stirring, into a vessel containing 300 ml of 5 mM potassium 
phosphate buffer (pH 7.2) containing lmM EDTA and 1 mM cys-
teine. The gradient was allowed to flow through the column 
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at the rate of 20 ml per hour. Fractions (10 ml) were col-
lected and analyzed for amidase activity and protein content 
(Lowry et al.; 1951). 
Storage of Purified Amidase 
The fractions making up the central portion of the peak 
of enzyme activity were combined and precipitated by the 
addition of ammonium sulfate (5.2 g per 8.3 ml of eluate) to 
give 90% (w/v) saturation. This mixture was centrifuged at 
25,000 x g for 15 minutes. The precipitate was collected 
and stored as a slurry at -20 C. For subsequent experiments, 
small aliquots of the enzyme slurry were dissolved in 50 mH 
potassium phosphate buffer (pH 7.2) containing 1 mH EDTA and 
1 mH cysteine and dialyzed extensively against this buffer 
prior to experimentation. All in ~itro investigations were 
performed in this buffer. 
Deoxyribonucleic Acid Isolation 
Growth of P. fluorescens 
Three Fernbach flasks (2800 ml) containing 500 ml of 
medium were inoculated from a liquid culture and incubated 
at 37 Con a reciprocal shaker. After 9 hours, the cells 
were harvested and washed twice with minimal salts buffer 
by centrifugation at 4 C and 5000 x g for 10 minutes. The 
w~t weight yield was between 12-15 g. The cells were re-
suspended in 0.15 M sodium chloride and 0.1 M EDTA at a con-
centration of 1 g (wet weight) per rnl. This suspension may 
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be used immediately or frozen at -20 C for later use. 
Isola.tion of DNA 
DNA from P. fluorescens was isolated utilizing the Saito 
and Hiura (1963) modification of the method described by 
Marmur (1961). Lysozyme (egg white) was added to a 6 g of 
resuspended cells to give a final concentration of 2 mg per 
mlo Incubation of this mixture at 37 C was carried out for 
a period of 10-20 minutes with careful monitoring, by the 
addition of dilute sodium hydroxide, to maintain a pH of 8.0.· 
Just as the cells began to lyse, they were quickly frozen in 
an acetone-dry ice bath.. At this time, 50 ml of Tris-SDS 
buffer (pH 9.0) consisting of 0.1 M Tris-HCl, 1% (w/v) sodium 
dodecyl sulfate (SDS) and Ool M sodium chloride was added to 
the frozen cells. Resuspension of the cells was accomplished 
by stirring with a glass rod. While lysis was still incom-
plete, the freezing and thawing were repeated. The cell sus-
pension was then mixed with an equal volume of redistilled 
phenol and the mixture was shaken by hand in a glass-stop-
pered round bottom flask for 20 minutes in an ice-water bath. 
The resulting emulsion was separated into 2 phases by low 
speed centrifugation at 4 C and 650 x g for 10 minutes. 
Clarification of the upper aqueous phase by high speed cen-
trifugation at 4 C and 16,300 x g for 10 minutes was used to 
remove any remaining cell debris. The nucleic acids were 
precipitated by gently mixing the clarified suspension with 
2 volumes of cold 95%. (v/v) ethanol. The thread-like 
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precipitate was collected on glass rods and dissolved in 
20-40 ml of dilute saline-citrate (pH 7.0) consisting of 15 
mM sodium chloride and 1.5 mM trisodium citrate. Two to four 
ml of concentrated saline-citrate (pH 7.0) consisting of laS 
M sodium chloride and Oal5 M trisodium citrate was then added 
to this solution, To remove RNA, ribonuclease I (bovine 
pancreas) which had been dissolved in 0.15 H sodium chloride 
and previously heated to 80 C for 10 minutes was added to the 
solution to give a final concentration of 50 ~g per ml. Af-
ter incubation for 30 minutes at 37 C, the digest was cooled 
and mixed with an equal volume of redistilled phenol, This 
was followed by shaking of the mixture for 10 minutes in an 
ice-water bath. The two phases were once again separated by 
centrifugation at 4 C and 650 x g for 10 minutes. As was 
done previously, the upper aqueous phase was clarified by 
centrifugation at 4 C and 16,000 x g for 10 minutes. The 
DNA was precipitated by the addition of 2 volumes of cold 
95% (v/v) ethanol and collected on glass rods, Next 1 the 
DNA was dissolved in 20 ml of dilute saline-citrate. To 
this mixture; 2~2 ml of acetate-EDTA (pH 7.0) consisting of 
3 M sodium acetate and 1 mM EDTA was added. While the solu-
tion was rapidly stirred, Oo54 volumes of cold isopropanol 
was slowly added to eliminate RNA. The precipitated DNA 
was subjected to the acetate-EDTA and isopropanol steps a 
second time using one-half the previous volumeso After this 
step, the DNA was washed by stirring successively in 70, 
80 and 90% (v/v) aqueous ethanol before storage at 4 C in 
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95% (v/v) ethanol and 1% (v/v) chloroform. 
Stock solutions of DNA were prepared by allowing the 
DNA to gently disperse in a small volume of the appropriate 
buffer over a period of 1-2 days at 4 C. Aliquots of this 
solution were removed and dialyzed against the experimental 
buffer to remove the remaining ethanol and chloroform. DNA 
concentration was determined by using either the diphenyla-
mine reaction (Burton, 1955), or by using a nomograph dis-
tributed by the California Corporation for Biochemical Re-
search, 3625 Hedford St., Los Angeles 63, California. The 
260/280 nm absorbencies were measured in a Beckman DU-2 
spectrophotometer using ~uartz cuvettes with a 1 em light 
path. RNA contamination was estimated using the orcinol 
method of Ogur and Rosen (1950). 
RNA Polymer'ase Assays 
Standard Assay of RNA Pol)"E:erase 
RNA polymerase activity was determined by measuring the 
amount of radioactive precursor rendered acid insoluble in 
the test system.. The standard assay procedure of McConnell 
and Bonner (1972) was used throughout the course of this 
investigation. ID~A polymerase (EC No. 2.7.7 .. 6), Type III 
from ~· coli K-12 (Sigma Chemical Company) was assayed in a 
total volume of 0.25 ml. The components of the assay con-
sisted of Tris-HCl buffer (pH 7.9), 50 mM; magnesium chloride, 
8 mH; dithiothreitol,· 0.1 ml1; ATP, GTP and CTP, each Oo2 !11M:; 
UTP, 0.19 mH; 5-3H-UTP (Amersham Corporation, specific 
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activity:2 curies per mmol), 0.01 mH; either calf thymus 
DNA (Sigma Chemical Company, Type I) or P .. fluorescens DNA 
(isolated and purified as previously described), 30 ~g; 3 
units of RNA polymerase. As defined by Sigma, one unit of 
RNA polymerase will incorporate 1 nanomole of labeled ATP 
into acid insoluble product in 15 minutes at pH 7. 9 at 37 C, 
using calf thymus DNA as the template. In this assay, acti-
nomycin D, protocatechuate and/or the hydroxypyrazole were 
added to the combined salt and ribonucleoside 5'-triphosphate 
solution before the DNA and &~A polymeraseo The reaction 
mixture was incubated at 37 C for 15 minutes. In some exper-
iments, 0.05 ml aliquots. of the reaction mixture were re-
moved at the desired time intervals and used to plot the 
radioactivity incorporated \vith time. The reaction was 
stopped by rapid cooling of the reaction mixture in an ice-
water bath followed by the addition of 75 ~g of RNA (Sigma 
Chemical Company, Type III from yeast) as a carrier and 2 
ml of 10% (w/v) trichloroacetic acid (TCA) in succession. 
After standing for 30 minutes in the ice-water bath. acid 
precipitable counts i.vere collected on glass fiber filters 
(Whatman GF/C, 2.4 em diameter) and washed 5 times with 10 
ml of cold 5% (w/v) TCA containing 0.1 H sodium pyrophosphate 
and 0.05 ml1 ATP. The filters were placed in scintillation 
vials and dried under a heat lamp. After cooling, 10 ml 
of Quantofluor (Hallinckrodt) was added to the vials and the 
vials were counted for 20 minutes in a Beckman LS-3133P 
scintillation counter, Controls lacking either RNA 
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polymerase or DNA were routinely included in each experiment. 
Time-Course Addition of Actinomycin Dt 
· Protocatechuate and the Hydroxypyrazole 
Time-course addition of actinomycin D, protocatechuate 
and the hydroxypyrazole was studied by using a slight modifi-
cation of the standard assay method, One of the compounds 
of interest was added to the complete reaction mixture lack-
ing CTP and incubated for 15 minutes at 37 C to establish a 
binding equilibrium with the template. This incubation \vill 
allow an initiation complex to form, At the end of this 
incubation period, the other compound of interest was added 
and elongation of the RNA chain may be started by the addi-
tion of CTP, or the incubation of the reaction mixture and 
the two compounds may be extended for another 15 minutes to 
establish a binding equilibrium between the two compounds 
and the template. Then, CTP was. added to start elongation. 
Controls incubated over these same periods were routinely 
included to insure that no loss of RNA polymerase activity 
was incurred. 
Effect on RNA Chain Elongation 
The high salt method of Hyman and Davidson (1970) was 
used to study the effect of the hydroxypyrazo1e on actino-
mycin D inhibition of fu~A chain elongation. The complete 
assay mixture lacking CTP was mixed in the low salt buffer 
of the standard assay. and incubated at 37 C for 15 minutes. 
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At this time, ammonium sulfate was added to give a final 
concentration of 0,4 H. This high salt concentration washes 
any non-initiated polymerase off the DNA; leaves the initia-
tion complex intact and severely slmvs the rate of reinitia-
tion. At this point, after initiation has occurred, 
actinomycin D and the hydroxypyrazole were added. Thus, only 
the effect of the compounds on ru~A chain elongation was 
measured. CTP may be added at this time, or after incubation 
at 37 C for an additional 15 minutes to allow the compounds 
to establish a binding equilibrium with the template. 
Treatment of Cells with 
Surface-Active Agents 
Four surface-active agents, Triton X-100, Tween 80, 
1-hexadecylpyridinium chloride and SDS, were investigated to 
determine the effect, if any, that these compounds might have 
on actinomycin D activity. Cultures of P. fluorescens were 
. -
grown for 9 hours at 37 C. The cells were harvested, washed 
twice with minimal salts buffer and resuspended in minimal 
salts buffer to give an optical density of 0,4 at 540 nm. 
Two 20 ml aliquots were removed and placed in Erlenmeyer 
flasks (250 ml). Five ml of the surface-active agent was 
added to one flask while 5 ml of sterile deionized water was 
added to the second flask. The two flasks were then incu-
bated on a slowly shaking water bath for 5 minutes at 37 C. 
At the end of this time period, the cells from the two 
flasks were harvested by low speed centrifugation at room 
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temperature, washed twice with minimal salts buffer and re-
suspended in minimal salts buffer to give an optical density 
of 0. 2 at 540 nm. These two suspensions v7ere then used to 
inoculate culture tubes containing the appropriate medium. 
Growth in the presence and absence of actinomycin D was fol-
lowed spectrophotometricallyo 
Uptake of Radioactive Substrates 
Cultures of P. fluorescens were grown for 9 hours at 
37 C. One ml of this growth suspension was used to inoculate 
24 ml of succinate medium contained in a side-arm flask (250 
ml). At the end of 3 hours, these cells were harvested, 
washed twice with minimal salts buffer and resuspended in 
minimal salts buffer to give an optical density of 0.3 mea-
sured at 540 nm. This cell suspension was equilibrated with 
gentle shaking for 20 minutes at 37 C in a shaking water 
batho Three ml of the cells were added to tubes containing 
the 14c-labeled substrate (0.2 pCi per ml final concentra-
tion), unlabeled substrate (10:1 molar ratio relative to 
the radioactive substrate) and the appropriate compounds of 
interest. Samples (Oo5 ml) were removed at the desired 
time intervals and immediately filtered through 11illipore 
filters (type HA, 0,45 micron pore size, 1 em diarneter) and 
washed 3 times with 1 ml of cold minimal salts buffer. The 
filters were placed in scintillation vials containing 10 ml 
of Aquasol (New England Nuclear), After 5 hours to insure 
complete digestion of the Hillipore filter, the samples were 
counted in a Beckman LS-3133P scintillation counter for 20 
minutes. 
Isolation, Purification and Reconstitution 
of Vesicles from Outer Hembrane 
Components of E.· fluorescens 
Extraction, Quantitation and 
Qualitation of Phospholipids 
Phospholipids were prepared by the method of Folch et 
al. (1957). After growth in succinate medium for 9 hours; 
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a 100 ml culture of P. fluorescens was harvested, washed 
twice with minimal salts buffer and resuspended in 5 ml of 
methanol contained in a screw-cap tube. The tube containing 
the suspension #as flushed with nitrogen and capped with a 
teflon lined screw-capo . The sealed tube was incubated for 
30 minutes in a 55 C water bath. After cooling to room tem-
perature, 10 ml of chloroform was added and the extraction 
was continued at 25 C fo~ 12 hours under a nitrogen atmos-
phere, Insoluble material was r.emoved from the sample by 
passing the suspension through a Hillipore filter (type HA, 
0.45 micron pore size). The chloroform-methanol suspension 
was then washed twice with 15 ml of 2 M potassium chloride 
and once with 10 ml of deionized water. After the water 
wash, the chloroform and water layers were separated by low 
speed centrifugation at room temperature, The resulting 
chloroform solution was passed through a freshly prepared 
sodium sulfate column (O.Sxl4 em) and dried down to about 
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0.5 ml under a steady stream of nitrogen. The phospholipid 
solution was maintained in chloroform at -20 C under a nitro-
gen atmosphere<) 
Since it is known that approximately 90% of the lipids 
of Pseudomonas aeruginosa and closely related species are 
phospholipids, the lipid phosphate content may be used as an 
assay of lipid levels (Hancock and Headow, 1969). Lipid 
phosphate was determined by the method of Ames and Dubin 
(1960) . 
The phospholipids were qualitatively identified by 
spotting microliter volumes of the chloroform-phospholipid 
solution on 5x20 em silica gel G chromatography plates 
(Quantum Industries) which had been activated at 100 C 
immediately before useo Chromatograms were developed in a 
solvent system of chloroform-methanol-water (65:25:4 by 
volume) after allowing the solvents to equilibrate for 1 
hour. Rhodamine· G spray reagent was used to detect lipid 
containing substances (Rouser et al.t 1961). The detection 
of phosphate esters was determined using the ferric chloride-
salicylsulphonic acid spray_reagent (Wade and Morgan, 1953). 
Ninhydrin spray reagent was used ·to detect lipids containing 
free amino groups (Marinetti et al., 1962). Phosphatidyl-
glycerol was detected by the Periodate-Schiff's test for 
vicinal hydroxyl groups (Shaw, 1968). Conclusive identifi-
cation of the extracted phospholipids was accomplished by 
chromatography with known standards. These standards in-
cluded phosphatidylethanolamine and phosphatidylglycerol 
49 
(Sigma Chemical Company). 
Lipopolysaccharide (LPS) from: P. fluorescens was ex-
tracted and purified by the method of Johnson and Perry 
(1976). Bacteria (5 g) were placed in 50 ml of 50 mM sodium 
phosphate buffer (pH 7.0) containing 2 rnM EDTA and Oo05% 
(w/v) sodium azide. This mixture was stirred with a magnetic 
stirrer at top speed for 1 minute. Lysozyme was added to 
give a final concentration of 100 pg per ml, and the suspen-
sion was slowly stirred at 4 C for 16 hours. After this 
incubation, the suspensi.on was then incubated at 37 C for 
20 minutes before stirring at top speed on a magnetic stirrer 
for 3 minutes. The volume of the suspension was adjusted to 
100 ml with 20 rnM magnesium chloride. Bovine pancreas ribo-
nuclease I and deoxyribonuclease I were added to give a final 
concentration of 1 pg per ml. This mixture was incubated 
for 10 minutes at 37 C and then for 10 minutes at 60 C. If 
a gelatinous mixture was obtained 1 the suspension was stirred 
for 3 minutes at top speed on a magnetic stirrer before 
phenol extractiono Equal volumes of disrupted bacteria and 
redistilled 90% (w/v) phenol were added to a glass-stoppered 
round bottom flask which was shaken by hand for 15 minutes 
in a water bath at 70 C. Both the bacterial suspension and 
the phenol were preheated to 70 C. After extraction, the 
suspension was rapidly cooled by shaking in an ice-water bath. 
Centrifugation at 4 C and 18,000 x g for 15 minutes permits 
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sharp definition of aqueous; phenol and interfacial layers, 
and occasionally sediment, The aqueous and phenol phases 
were carefully removedo The aqueous phase was retained while 
the phenol phase was discarded. Material remaining after 
removal of the aqueous and phenol phases was resuspended in 
three volumes of deionized water and stirred on a magnetic 
stirrer for 5 minutes. This suspension was centrifuged at 
4 C and 18,000 x g for 15 minutes, and the resultant super-
natant fraction was removed and combined with the aqueous 
phase. The pooled aqueous phases were dialyzed against de-
ionized water until no detectable phenol odor remained. The 
samples were lypholized and stored at -20 C. 
Quantitation of LPS was determined by the L-glycero-D-
mannoheptose assay of Osborn (1963) and the 2-keto-3-deoxyoc-
tonate (KDO) assay of Weissbach and Hurwitz (1958). LPS 
concentrations were calculated by assuming that each mole of 
LPS contained 2 moles of heptose. 
Outer Hembrane Protein Isolation 
and Purification 
The method of Hancock and Nikaido (1978) was used to 
prepare outer membranes of P. fluorescenso Nine liters of 
cells were grown in succinate medium for 9 hours and har-
vested by centrifugation at 4 C and 5000 x g for 10 minutes. 
The cells were washed with 30 mH Tris-HCl buffer (pH 8.0) 
artd resuspended in 20 ml of 20% (w/v) sucrose in Tris-HCl 
buffer containing l mg each of bovine pancreatic 
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deoxyribonuclease I and ribonuclease I. The cells were 
passed twice through a French pressure cell at 15,000 pounds 
per square inch, after which 2 mg of egg white lysozyme were 
addedo Ten minutes later, a·protease inhibitor (alpha-tolu-
lenesulfonyl fluoride) was added to give a final concentration 
of 1 ml-fo Cell debris was removed by centrifugation at 4 C 
and 1000 x. g for 10 minuteso The supernatant was decanted, 
diluted by the addition of Tris-P.Cl buffer and layered onto 
sucrose step gradients containing 1 ml of 70% (w/v) sucrose 
and 6 ml of 15% (w /v) sucrose in 30 m}f Tris-HCl buffer. 
These tubes were centrifuged at 4 C and 183,000 x g for 1 
hour in a BeckiT~n SW 41 rotor. The bottom 2 ml of each gra-
dient was removed, pooled, diluted and applied to sucrose 
density gradients containing steps of 5 ml 70%, 10 ml of 64%, 
10 ml of 58%, and 10 ml of 52% (w/v) sucrose in 30 mN Tris-
ECl buffer. These tubes were centrifuged at 4 C and 96,000 
x g for 18 hours in a Beckman SW 27 rotor. The four bands 
which were observed were removed by dropwise collection from 
the bottom of the centrifuge tube and assayed for protein 
(Lowry et al 0 , 1951), succinate dehydrogenase (Kasahara and 
Anraku, 1974-), KDO (Weissbach and Hurwitz; 1958) and lipid 
phosphate (Ames and Dubin, 1960). 
Fractionation of outer membrane proteins was performed 
according to the procedure of Hancock et alo (1979)o The 
lower 2 bands were pooled, diluted with sterile deionized 
water and centrifuged at 4 c· and 177,000.x g for 1 hour in 
a Beckman SW 41 rotor. The resulting pellet was solubilized 
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at a protein concentration of 10 mg per ml in 20 mH Tris-HCl 
buffer.(pH 7.4) containing 2% (v/v) Triton X-100 with soni-
cation for 2 minutes in a bath type sonicator (Laboratory 
Supplies ·company, Inc,)o Insoluble protein was sedimented 
by centrifugation at 4 C and 177,000 x g for 1 hour, and the 
supernatant was set aside as Triton X-100 soluble protein. 
Triton X-100 insoluble protein was resuspended in 20 rnM Tris-
HCl buffer (pH 7.4) containing 2% (v/v) Triton X-100 and 10 
mM EDTA at a protein concentration of 8 mg per ml with soni-
cation as above to assist solubilization. Triton X-100/EDTA 
insoluble protein was remDved by centrifugation at 4 C and 
177,000 x g for 1 hour ~n a Beckman SW 41 rotor. The super-
natant, containing Triton X-100/EDTA soluble outer membrane 
proteins was applied to a column (2o7x40 em) of DEAE-Sephacel 
(Pharmacia Fine Chemicals) which had been equilibrated with 
20 rrM Tris-HCl buffer (pH 7.4) containing 0.1% (w/v) Triton 
X-100 and 10 mH EDTA, The proteins were eluted at a linear 
flow rate of 8 em per hour by using a Pharmacia gradient 
mixer to form a concentration gradient of sodium chloride 
(0 0 1 to 0.6 M). Fractions of 7 ml were collected, assayed 
for protein content (Lowry et al;, 1951), and appropriate 
fractions were pooled. The pooled fractions were concentrated 
to about 3-5 ml by dialysis against a 30/o (w/v) solution of 
polyethylene glycol 6000o Triton X-100 was remDved from the 
protein samples by treatment with Bio-Gel SM-2 copolymer 
beads (Bio-Rad Laboratories)' by the method of Holloway (1973). 
·The assay procedure of Garewal (1973) was used to determine 
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Triton X-100 concentrations. After removal of Triton X-100, 
the protein fractions were divided into 0.5 ml aliquots and 
stored at -20 C in polypropylene micro test tubes. 
Vesicle Preparation 
Outer membrane vesicles were reconstituted by the tech-
nique described by Hancock and Nikaido (1978). Phospholipids 
(0.5 micromole)·were dried down under a stream of nitrogen 
in disposable borosilicate tubes before placing the tubes in 
an evacuated dessicator for 30 minutes. LPS (0.08 micromole), 
with or without outer membrane protein (125-140 ~g) derived 
from the outer w.embrane .band material, was added to the tube 
and mixed on a Vortex mixer for 30 seconds. This mixture 
was then sonically disrupted in a bath type sonicator for 
60 seconds to thoroughly randomize the components. The sus-
pension was dried down under a stream of nitrogen at 45 C. 
The tubes were then placed in an evacuated dessicator for 
30 minutes. A 100 microliter volume of a solution containing 
1 mM N-2-hydroxyethylpiperazine-li'-2-ethanesulfonic acid 
(HEPES) buffer (pH 7.4), 100 ~~sodium chloride, 10 mM 
magnesium chloride and 4.4 x 105 cpm of u-14c-sucrose was 
added. The vesicle components were resuspended with a teflon 
spatula, followed by mixing for 30 seconds on a Vortex mixer 
and 30 seconds of sonic disruption in a sonicating water 
bath. The tubes were then incubated in a water bath at 45 C 
for 30 minutes. At the end.of this time period, the water 
bath was turned off and allowed to come slm,rly, over the 
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course of approximately 2 hours, to room temperatureo Ali~ 
quots of the vesicle solution were diluted 100 fold into a 
solution containing l rrM HEPES buffer (pH 7.4), 100 rnM sodium 
chloride, 10 mM magnesium chloride and 3 mM sodium azide. 
The effect of selected compounds on 14c-sucrose retention 
was determined by exposing reconstituted vesicles to the 
compounds which were included at the desired concentration 
in this buffer. After 20 minutes at 25 C, the diluted ves-
icle suspension was filtered slowly, over the course of 
about 20 seconds, through a Hillipore filter (type HA, 0.45 
micron pore size, 1 em diameter). The filter was washed 
six times with 1. 5 ml of the buffer previously described, 
The washed filters were placed in scintillation vials con-
taining 10 ml of Aquasol (New England Nuclear). After 5 
hours to insure complete digestion of the Hillipore filter; 
the amount of radioactivity retained in the vesicles was 
determined by liquid. scintillation ·counting in a Beckman 
LS-3133P scintillation counter for 50 minutes. The amount 
of 14c-sucrose retained in the.-vesicles was divided by the 
14c-sucrose content of the reconstitution medium to calculate 
the% 14c-sucrose retained within the vesicles. 
SDS Polyacrylamide Gel Electrophoresis 
of Outer Hembrane Proteins 
SDS polyacrylamide gel electrophoresis was performed by 
the method of Lugtenberg et'al. (1975). The discontinuous, 
·.vertical slabs used in this investigation had a thickness of 
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1 mm and a running length of 9 cmo The following stock so-
lutions were used for .the preparation of the running and 
stacking gels. Stock solution I contained 44 g of acrylamide 
plus 0.8 ·g of methylene bisacrylamide while stock solution 
II contained 30 g of acrylamide plus 0.8 g of methylene bis-
acrylamide. ·The volumes of both solutions were adjusted to 
100 ml with sterile deionized water, filtered through Whatman 
No. 1 paper and stored at 4 C in the darko- A fresh solution 
of ammonium persulphate was prepared for each slab gelo 
Polymerization was initiated by the addition of N,N,N' ,N'-
tetramethylethylenediamine (TEMED) to yield a final concen-
tration of 0.2% (v/v). The running and stacking gel solutions 
were degassed before the gel was poured and polymerized. 
The running gel contained 3.125 ml of stock solution I, 
0.315 ml of ammonium persulphate (10 mg per ml), 0.25 ml of 
10% (w/v) SDS, 6.25 ml of Oo75 H Tris-HCl buffer (pH 8.8), 
2.56 ml deionized water and 0.025 ml of TEMED. The stacking 
gel contained 0.5 ml of stock solution II, 0.12 ml of ammonium 
persulphate (10 mg per ml), 0.05 ml of 10% (w/v) SDS, 2~5 
ml of 0.25 M Tris-HCl buffer (pH 6.8), 1~83 ml of deionized 
water and 0.01 ml of TEHED. The buffer (pH8.3) for both 
electrodes contained 0.025 M Tris-HCl, 0.19 M glycine and 
0.1% (w/v) SDS. 
Protein samples were prepared in 0.0625 H Tris-HCl buf-
fer (pH 6.8) containing 2% (w/v) SDS, 10% (v/v) glycerol, 
0~001% (w/v) bromophenol blue and 5% (v/v) 2-rnercaptoethanol. 
·Protein was added to .give a. final concentration of 0.5-1 mg 
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per ml, and the samples were boiled for 5 minutes. 
·Routinely, 20 microliters (20 pg protein) of the samples 
were applied per slot. Samples containing a mixture of 1 pg 
each of standard proteins (Sigma Chemical Company) were pre-
pared and applied as described. Electrophoresis was performed 
at room temperature using a constant current of 20 mAo The 
electrophoresis was stopped when the tracking dye had migrated 
to within 1 em from the bottom of the gel. Gels were stained 
overnight in 0.1% (w/v) Coomassie Blue in 50% (v/v) methanol 
and 10% (v/v) acetic acid. The slabs were destained in 50% 
(v/v) methanol and 10% (v/v) acetic acid. In order to store 
the gels, they were soaked for additional 24 hours in a solu-
tion containing 50% (v/v) methanol and 5% (v/v) glycerol. 
After this treatment, the gels were spread on Hhatman 311M 
chromatography paper and drie4 in a glazing dryer. 
CHAPTER III 
RESULTS AND DISCUSSION 
Influence of the Hydroxypyrazole and 
Protocatechuate on the Actinomycin D 
Inhibition of P. fluorescens 
Effect of Actinomycin D on 
Growth of P. fluorescens 
Waksman (1954) reported that Gram-positive microorgan-
isms were very susceptible to actinomycin D action while 
Gram-negative microorganisms were less affected. The effect 
of the antibiotic can be both bacteriostatic and bactericidal, 
depending upon the concentrations utilized. 
Tube dilution assays were performed in succinate medium 
to determine the sensitivity of E_. fluorescens to actinomycin 
D. The response of this bacterium to actinomycin D concentra-
tions of 3.2 x lo-6, 8.0 x lo-6, 1.6 x lo-5 and 2.4 x lo-5 M 
demonstrated that inhibition of grm11th was concentration de-
pendent (Figure 6). Only slight inhibition of growth was 
observed when the concentration of actinomycin D was 3.2 x 
10.;_6 M, while growth was completely inhibited when t~1.e con-
centration was increased to '2a4 x lo-5 M. Nearly 1-2 hours 
· of growth in the presence of actinomycin D was required 
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Figure 6. Effect of Actinomycin D on Grmvth of Po fluores-
cens. e , succinate control; 0 , -actinomycin 
n;-3.2-x 10'"'6 H; 0 ; actinomycin D, 8.0 x lo-6 
M; 6 , actinomycin D, 1. 6 x lo-5 M; 0 , acti-
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before any of the concentrations produced a discernible 
degre'e of inhibitiono · This period is assumed to represent 
the time required for actinomycin D to pass into the cell, 
reach its primary site of action (the DNA) and inhibit RNA 
synthesis. 
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Microscopic examination of cells exposed to the higher 
concentrations of actinomycin D revealed that these cells 
exhibited increases in both length andwidth. 
Effect of the Hydroxypy~azole on 
Growth of P. fluorescens 
Haslam (1973) reported that the hydroxypyrazole was a 
potent growth inhibitor of B. subtilis H23. A concentration 
of 8oS x 10-6 H completely inhibited growth of this organism 
for 6 hours. LM tissue culture cells were also sensitive to 
the hydroxypyrazole. However, a concentration of 8.5 x lo-5 
M was necessary to decrease the .number of viable tissue 
culture cells by 60%. 
In contrast, tube dilution assays demonstrated that P. 
fluorescens was not inhibited byhydroxypyrazole concentra-
tions as high as 1. 3 x lo-4 M. The inability of the 
hydroxypyrazole to inhibit growth of P. fluorescens is in 
agreement with the report by Smith et al. (1963) which noted 
that the spectrum of activity of steroids was almost totally 
confined to Gram-positive microorganisms. 
Effect of the Hydroxy:E;:razole on 
Actinomlcin D Inhibition of 
P. fluorescens 
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Actinomycin D inhibition of P. fluorescens was increased 
by approximately 70% when the hydroxypyrazole was added in 
combination to the medium (Figure 7)o The concentrations of 
actinomycin D and the hydroxypyrazole used in this study 
were 3.2 x lo-6 and 4.2 x lo-S M, respectively. The very 
significant increase in actinomycin D inhibition resulting 
from the addition of the hydroxypyrazole appears to be bac-
tericidal in nature. Neither prolonged incubation, nor 
washing and resuspension of the cells in fresh medium in the 
absence of actinomycin D was sufficient to reinitiate growth 
after exposure for 10 hours to the combination of these 
compounds. This is interesting since the concentration of 
actinomycin D used in this investigation was bacteriostatic. 
Furthermore, increases in cell iength and width were observed 
microscopically which were customarily observed only for 
cells exposed to higher concentrations of the antibiotic. 
Cell viability experiments utilizing the same concentra-
tions which were used in the tube dilution assays revealed 
that there was a steady decline in the number of viable 
cells exposed to the combination of actinomycin D and the 
hydroxypyrazole, while the control cells and actinomycin D 
treated cells' increased in viable cell number (Figure 8). 
These data suggest that a molecular interaction between 
actinomycin D and the hydroxypyrazole may participate in the 
Figure 7 .. Effect of the Hydroxypyrazole on Actinomycin D 
Inhibition of Growth of P. fluorescens. e , 
succinate control and hydroxypyrazole, 4.2 x 
10""'5 11; e , actinomycin D, 3. 2 x lo-o M; • , 
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Figure 8o Effect of the Hydroxypyrazole on Actinomycin D 
Inhibition of P, fluorescens Cell Viability. 
e , succinate-contro 1 and liydroxypyrazole, 
4.2 x. lo-5 M; .& , actinomycin D, 3.2 x 10-6M. 
• , hydroxypyra.zole plus actinomycin D. 
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mechanism(s) by which actinomycin D action is increased. 
Previous investigation in this laboratory by Haslam (1973) 
initially provided evidence supporting the complexation of 
actinomycin D and the hydroxypyrazole. Further evidence 
from lH NMR analysis in DzO (Chestnut et al., 1974), and 
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lH NMR and 13c ffi1R analysis in n3con (O'Donnell et al., 1978) 
augment this investigation. 
Most attempts to potentiate actinomycin D action have 
utilized agents such as EDTA, detergents and bacteriophage 
to create permeability changes in the cell which allow more 
actinomycin D to diffuse into the cell. Although this type 
of action cannot be completely ruled out for the hydroxy-
pyrazole, growth experiments have shown that the hydroxy-
pyrazole appears to neither inhibit cell growth or cause 
aberrant changes in cell size at the concentrations used in 
this investigation. Furthermore, studies have shown that 
exposure of P. fluorescens to only the hydroxypyrazole does 
not result in an increase in actinomycin D action, P. 
· fluorescens was grown for 8 hours in the presence of the 
hydroxypyrazole, washed t\vice with minimal salts buffer and 
resuspended in succinate medium containing actinomycin D. 
No difference was observed between the cells grown in the 
presence of the hydroxypyrazole and cells grown in succinate 
medium \vhen both batches of cells were exposed to actinomycin 
D. Therefore, it appears from these data that the hydroxy-
pyrazole and actinomycin D must both be present and act 
together, possibly via a molecular complex, to inhibit growth 
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of P. fluorescens. 
'It is interesting to note that it was also approximately 
1-2 hours after exposure to the combination of the hydroxy-
pyrazole and actinomycin D before noticeable inhibition of 
growth was observed. This was not unlike the inhibition 
which was observed for a corresponding concentration of ac-
tinomycin D. 
Prevention and Reversal of Actinomycin D 
Inhibition bx Protocatechuate 
Durham and Keudall (1969) observed that protocatechuate 
could prevent or reverse the inhibition by actinomycin D of 
P. fluorescens without interfering with the diffusion of 14c-
actinomycin D into the cell. Protocatechuate, at a concen-
tration of 6.5 x lo-4 M, was observed to prevent or reverse 
the inhibition of growth of ~· fluorescens resulting from 
an actinomycin D concentration of 1.6 x lo-5 M (Figure 9). 
Cell viability studies have shown that increases in viable 
cell number accompany the increases in absorbance which have 
been observed for P. fluorescens grown in the presence of 
protocatechuate and actinomycin D. The specificity that 
appears to be involved in the ability of the protocatechuate 
to alleviate actinomycin D action in this organism suggests 
that molecular complexation between these compounds probably 
plays an integral role in the mechanism(s) which may be 
employed. Also, it is important to note that the concentra-
tion of protocatechuate which was used i"n this study did not 
Figure 9. Prevention and Reversal of Actinomycin D 
Inhibition of Growth of P. fluorescens by Proto-
catechuateo e , succinate control and proto-
catechuate, 6.5 x lo-4 M; ~ , actinomycin D, 
1. 6 x 10 ... 5 M; • , actinomycin D plus protocate-
chuate added at 0 hours; tt , actinomycin D 
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affect growth of the cells. 
Prevention and Reversal of Inhibition 
Resulting from the Combination of 
Actinomycin D and the Hydroxypyrazole 
by Protocatechuate 
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Experiments were conducted to determine if protocate-
chuate would prevent or reverse the inhibition resulting from 
the combination of actinomycin D and the hydroxypyrazole. 
The results demonstrated that protocatechuate could prevent 
or reverse the increased inhibition which was observed when 
the hydroxypyrazole and actinomycin D were added in combina-
tion to the medium (Figure 10). The concentrations of pro-
tocatechuate, the hydroxypyrazole and actinomycin D were 
6.5 x lo-4, 4.2 x lo-S and 3.2 x 10-6M, respectively. The 
ability of protocatechuate to relieve this inhibition appears 
to be similar to its. capacity to alleviate the inhibition 
resulting from only actinomycin D. The trends which were 
observed by following the growing cultures spectrophotometri-
cally were supported by cell viability experiments which 
showed that prevention and reversal of the inhibition re-
sulting from these two compounds was the consequence of 
increases in viable cell number (Figure 11). These data 
suggest that protocatechuate may be interacting with acti-
nomycin D or the proposed hydroxypyrazole:actinomycin D 
complex to decrease its ability to inhibit the growth of 
P. fluorescens. 
Figure 10. Prevention and Reversal of Inhibition of Growth 
of P. fluorescens Resulting from the Combina-
tLon of ActLnomycin D and the Hydroxypyrazole 
by Protocatechuate. e , succinate control, 
hydroxypyrazole (4.2 x lo-S M), protocate-
chuat§ (6.5 x lo-4 M), and actinomycin D (3.2 
x lo-b M) plus hydroxypyrazole plus protocate-
chuate added at 0 hours; • , actinomycin D 
plus hydroxypyrazole; A , actinomycin D plus 
hydroxypyrazole plus, protocatechuate added 
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Figure llo Prevention and Reversal of Inhibition of P. flu-
orescens Cell Viability Resulting from the--
Combination of Actinomycin D and the Hydroxy-
pyrazole by Protocate.chuate. e , succinate 
control, hydroxypyrazole (4.2 x lo-S H), pro-
tocatechuate (6.5 x lo-4 M)t and actinomycin 
D plus hydroxypyrazole plus protocatechuate 
add~d at 0 hours; • , actinomycin D (3. 2 x 
10- 11); • ; actinomycin D plus hydroxypy-
razole; 4t , actinomycin D plus hydroxypyra-
zole plus protocatechuate added at 2 hours. 
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~ 





2 4 6 
TIME <HOURS l 
Influence of the Hydroxypyrazole and 
Protocatechuate on Actinomycin D 
Inhibition of Amidase Synthesis 
by P. ·fluor esc ens 
Effect of Acti~mycin D on 
Amidase Synthesis 
75 
Actinomycin D inhibition of amidase synthesis was com-
parable to actinomycin D inhibition of growth in this organism 
since inhibition of both amidase synthesis and growth are 
concentration dependent. However, amidase synthesis is about 
10 times more sensitive·to the antibiotic. Actinomycin D at 
concentrations of 3.2 x lo-7 and 3.2 x 10-6 M inhibited 
amidase synthesis by approximately 5% and 100%, respectively 
(Figure 12). Thus, the monitoring of amidase synthesis 
provides a more sensitive and direct method for determining 
changes in actinomycin D action. 
Effect of the Hydroxypyrazole on 
· Amidase Synthesis 
Several concentrations of the hydroxypyrazole were tested 
to determine if this compound could inhibit amidase synthesis 
by P.· fluorescens. No inhibition of amidase synthesis was 
observed; even at concentrations as high as 1.3 x lo-4 H. 
Figure 12. Effect of Actinomycin D on Amidase Synthesis. 
e , succinate plus acetamide control; 4t , 
actinomycin D, 3. 2 x lo-7 M~ • , actinomycin 
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Effect of the Hydroxlp¥razole on 
Actinomycin D Inhibition of 
Amidase Synthesis 
The inhibition of amidase synthesis by actinomycin D, 
78 
at a concentration of 3.2 x lo-7 11, was increased by nearly 
50% when the hydroxypyrazole, at a concentration of 4.2 x 
lo-S M, was added in combination to the medium (Figure 13). 
These results agree with those of Blunk (1977), although it 
was determined in this investigation that the hydroxypyrazole 
concentration required to achieve this degree of inhibition 
was one-half the amount which was previously reported. The 
increase in actinomycin D inhibition of amidase synthesis 
when the hydroxypyrazole was present in the medium provides 
further evidence that a molecular interaction between the 
hydroxypyrazole and actinomycin D may function to increase 
actinomycin D action. Regardless of the mechanism(s) in-
volved, an important circumstance which results from growth 
in the presence of the hydroxypyrazole and actinomycin D is 
a decrease in protein synthesis~ 
Effect of the Hydroxz12yrazole and 
Actinomycin D on Amidase Activitz 
In order to eliminate the possibility that the hydroxy-
pyrazole, actinomycin D or combinations of these compounds 
inactivate the amidase enzyme rather than its synthesis, in 
vitro investigations were performed with amidase which was 
isolated from P. fluorescens. Amidase is a hexameric protein 
Figure 13. Effect of the Hydroxypyrazqle on Actinomycin D 
Inhibition of Amidase Synthesis. 8 , succi-
nate plus acetamide control and hydroxypyrazole 
(4.2 x 10'"'5 H); e , actinomycin D (3.2 x l0-7 
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with identical subunitso The molecular weight of the oligomer 
was found to be 200,000 daltons while the subunits have mole-
cular weights between 33.000 and 35,000 daltons (Brown et 
al. • 1973). 
The method of Kelly and Kornberg (1964) was used to 
isolate and purify amidaseo Ultrasonic extracts of P. flu-
orescens were prepared and treated with deoxyribonuclease I 
before ammonium sulfate precipitation was used to recover 
the bulk of the protein content. After extensive dialysis, 
the dialyzed protein was applied to a DEAE-cellulose column 
and a phosphate gradient was used to elute the amidase from 
the DEAE-cellulose. Fr~ctions (10 ml) were collected and 
analyzed for amidase activity and protein content (Figure 
14). Most of the amidase activity was eluted between 40 and 
80 mM phosphate. Fractions cqmprising the central portion 
of the peak of enzyme activity were combined and precipitated 
by addition of ammonium sulfate. The resulting slurry was 
stored at -20 C and prepared for in vitro investigation by 
dialysis to remove ammonium sulfate. 
Experiments were designed to study the effect of the 
hydroxypyrazole, actinomycin D or combinations of these com-
pounds on amidase activity. Amidase was added to tubes 
containing the appropriate compounds to yield a protein con-
tent of 0.233 mg per mlo The tubes were incubated at 37 C 
and 0.25 ml aliquots were removed at the designated time 
intervals. These aliquots were immediately assayed to de-
termine enzyme activity. None of the concentrations or 
Figure 14. Elution of Amidase of Po fluorescens from DEAE-
Cellulose. e e , specific activity; A--& , 
protein. 
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combinations of the hydroxypyrazole and actinomycin D affected 
amidase activity-over this time-course (Table I). Identical 
experiments utilizing either higher or lower concentrations 
of amidase provided the same results. It is important to 
note that the concentrations of thehydroxypyrazole and 
actinomycin D (4.2 x lo-5 and 3.2 x lo-7 M respectively) 
which were responsible for the increase in actinomycin D 
inhibition of amidase synthesis (Figure 13) had no effect on 
amidase activity. Also, actinomycin D at a concentration of 
3.2 x 10-6 H had no effect even though this concentration 
completely inhibited amidase synthesis. In addition, the 
proposed complex of the hydroxypyrazole and actinomycin D 
did not inactivate amidase since neither of the tubes con-
taining 1:1 molar ratios of these compounds at 3.2 x lo-7 
and 3.2 x lo-6 differed from the control. 
Prevention and Reversal of Actinomycin D 
Inhibition of Amidase Synthesis 
b~ Protocatechuate 
Prevention and reversal of actinomycin D inhibition of 
amidase synthesis by protocatechuate was first reported by 
Ferguson (1970). A study by Durham and Ferguson (1971) of 
selected benzoic acid derivatives reported that protocate-
chuate exhibited the greatest potential for mitigating acti-
nomycin D inhibition of amidase synthesis. Protocatechuate 
at a concentration of 6.5 x lo-4 H can completely prevent 
and almost totally reverse the inhibition of amidase synthesis 
TABLE I 
EFFECT OF THE HYDROXYPYRAZOLE 
AND ACTINOMYCIN D ON 
AMIDASE ACTIVITY 
Specific Activity 
Concentration of Compounds umoles acetohydroxamate Eroduced 
(Molarity) 15 minutes/mg protein 
Actinomycin D Hydroxypyrazole 0.0 hrs 1.0 hrs 2.0 hrs 3.0 hrs 
0.0 0.0 3128 3117 3154 3138 
3.2 x Io-7 0.0 3117 3092 3097 3092 
0.0 3.2 x lo-7 3154 3143 3159 3164 
0.0 3.2 x 1o-6 3148 3179 3169 3190 
0.0 4._2 x 1o-s 3138 3097 3128 3128 
3.2 x lo-7 3.2 X lo-7 3117 3169 3148 3128 
3.2 x Io-7 4.2 x 1o-s 3092 3086 3138 3086 
3.2 x 1o-6 o.o 3117 3117 3107 3148 
0.0 3.2 x 1o-6 3169 3092 3174 3107 
0.0 4.2 x 1o-s 3076- 3128 3117 3097 
3.2 x 1o-6 3.2 x 1o-6 3107 3169 3148 3148 
3.2 X 10-6 4.2 X 10-5 3154 3138 3128 3097 
*The amidase concentration was 0.233 mg/ml. 
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resulting from 3.2 x 10-6M actinomycin D (Figure 15). The 
ability of protocatechuate to relieve the inhibition of 
amidase synthesis by a concentration of actinomycin D which 
produced 100% inhibition provides additional support that 
the efficacy of this compound to diminish actinomycin D 
action may involve molecular interaction between these com-
pounds. 
Prevention and Reversal of Inhibition 
of Amidase Synthesis Resulting froin the 
Combination of Actinomycin D and t£~ 
Hydroxypyrazole by Protocatechuate 
In a manner similar to that observed for growth inhibi-
tion of P. fluorescens, protocatechuate (6.5 x lo-4 H) 
prevents and reverses the inhibition of amidase synthesis 
resulting from the combination of the hydroxypyrazole (4.2 
x lo-5 M) and actinomycin D (3.2 x lo-7 M) (Figure 16). 
These data confirm the earlier report by Blunk (1977) even 
though slightly different concentrations of the hydroxypyra-
zole and protocatechuate were used in this investigation. 
Therefore, it appears that an important element of protoca-
techuate's circumvention of either actinomycin D, or actino-
mycin D and hydroxypyrazole action may involve molecular 
complexations. 
Figure 15. Prevention and Reversal of Actinomycin D Inhi-
bition of Amidase Synthesis by Protocatechuate. 
e , succinate plus acetamide control; proto-
catechuate (6o5 x lo-4 M)t and actinomycin D 
(3,2 x 10~6 M) plus protocatechuate added at 0 
hours; A , actinomycin D; • 1 actinomycin D 
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Figure 16o Prevention and Reversal of Inhibition of Amidase 
Synthesis Resulting from the Combination of 
Actinomycin D and the Rydroxypyrazole by Pro-
tocatechuate. e 1 succinate plus acetamide 
control; hydroxypyrazole (4.2 x 10""5 11), pro-
tocatechuate (6.5 x lo-4 M), and actinomycin 
D (3.2 x lo-7 11) plus protocatechuate added 
at 0 hours; • ~ actinomycin D plus hydroxy-
pyrazole; A. , actinomycin D plus hydroxypy-
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Influence of the Hydroxypyrazole and 
Protocatechuate on Actinomycin D· 
Inhibition of the RNA 
Polyrr~rase Reaction 
91 
Actinomycin D binds to DNA and subsequently inhibits 
RNA chain elongation by affecting the rates at which CTP and 
GTP are incor~orated (Hyman and Davidson 1 1970). On the 
macroscopic level; the overall incorporation of the four 
ribonucleoside 5'-triphosphates is decreased equally. Trans-
cription still proceeds linearly along the template, so that 
the base composition of the fu~A is complementary to the 
transcribing strando The steps at which CTP and GTP are 
incorporated are slowed down while the steps at which ATP 
and UTP are incorporated are not. A precise mechanism 
accounting for this inhibition has not been elucidated. In 
vitro RNA polymerase assays were designed and conducted to 
study the influence of the hydroxypyrazole and protocate-
chuate on actinomycin D inhibition of this reaction because 
it is the primary biological site of action for actinomycin 
D. In addition, the data from the amidase investigations 
have revealed that both the hydroxypyrazole and protocate-
chuate function to modulate actinomycin D inhibition of 
amidase synthesis. The sensitivity of the RNA polymerase 
reaction to actinomycin D provides a useful system for 
detecting subtle differences in actinomycin D binding. 
Effect of Actinomycin D on 
!;he RNA Polymerase Reaction 
92 
Actinomycin D does not bind to the Rl~ polymerase, or 
interfere with its binding to the DNA template and subsequent 
initiation of RNA synthesis. For a given concentration of 
DNA, the actinon:ycin D inhibition of the RNA polymerase 
reaction is concentration dependent. This was observed in 
the course of this investigation. Utilizing the standard 
assay, increasing concentrations of actinomycin D were added 
to reaction mixtures containing 30 ~g of calf thymus DNA 
(Figure 17). Very small increases in the concentration of 
actinomycin D resulted in very large increases in inhibition. 
This behavior was observed until approximately 70% inhibition 
was achieved, whereupon the degree of inhibition was only 
slightly increased with increasing concentrations of actino-
mycin D. Regardless of the actinomycin D concentration, 
some RNA was always synthesized. 
Effect of the Hydroxypyrazole on 
the RNA Polymerase Reaction 
The hydroxypyrazole was observed to inhibit the ruqA 
polymerase reaction when assayed utilizing the same assay 
conditions as were used for actinomycin D (Figure 18). This 
result was not unexpected since Blunk (1977) demonstrated 
that the hydroxypyrazole binds to DNA to stabilize the DNA 
helix and shift the melting curve to higher temperatures. 
However, the concentration of the hydroxypyrazole which was 
Figure 17. Effect of Actinomycin Don the ru{A Pol~nerase. 
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Figure 18. Effect of the Hydroxypyrazole on the ID~A Polymer-
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necessary to establish inhibition was more than 10 fold 
greater than the corresponding concentration of actinomycin 
D. Moreover, only 30-35% inhibition was achieved with higher 
concentrations of the hydroxypyrazole. 
The mechanism by which the hydroxypyrazole binds to DNA 
and inhibits the RNA polymerase reaction is not known. It 
is of interest that the steroidal diamine, irehdiamine A, 
also stabilizes DNA from thermal denaturation at low concen-
trations. Sobell (1973) reported that irehdiamine A may bind 
to DNA by an intercalative mechanism. In an intercalative 
model, the steroid nucleus fits between base pairs in the 
DNA helix resulting in local denaturation of base pairs im-
mediately above and below the intercalation site. The 
binding may be stabilized by electrostatic interactions 
between the protonated amino groups of irehdiamine A and 
opposite DNA chains. Although the hydroxypyrazole has no 
protonated amino groups to stabilize its binding, an inter-
calative binding mechanism may explain its unusual effects 
on RNA synthesis. 
A unique observation was noted when the hydroxypyrazole 
concentration was decreased to 3.2 x lQ-7 M. This concen-
tration, which was 10 fold less than the concentration re-
quired to establish inhibition, produced a significant 
stimulation of the RNA polymerase reaction. The rationality 
of this stimulation will be discussed in following sections. 
Effect of the Hydroxypyrazole on 
Actinomycin D Inhibition of the RNA 
Pol~erase Reaction 
98 
The effect of a 1:1 molar ratio (3o2 x lo-7 M) of the 
hydroxypyrazole and actinomycin D on RNA synthesis was in-
vestigated using the standard assay method. This combination 
of the hydroxypyrazole and actinomycin D produced approxi-
mately 21% more inhibition than the actinomycin D control 
when calf thymus DNA was used as the template (Table II). 
As was mentioned in the previous section, the hydroxypyrazole 
stimulated total RNA synthesis by nearly 13%. A time-course 
experiment demonstrated that both the hydroxypyrazole and 
complete controls synthesized RNA at a linear rate over this 
time period (Figure 19). These results also showed that both 
the actinomycin D control and the combination of the hydroxy-
pyrazole and actinomycin D synthesized RNA at approximately 
the same rate as the complete control for the first few 
minutes of the reaction before declining with time. 
Similar results were obtained when DNA isolated from 
P. fluorescens was used as the template (Table III). There-
fore, the increase in actinomycin D inhibition of RNA syn-
thesis by the hydroxypyrazole is not limited to one template. 
However, P. fluorescens DNA appears to be less efficient as 
a template than calf thymus DNA. This dissimilarity is pro-
bably the result of preparation rather than differences in 
base composition. 
T~LE II 
EFFECT OF THE HYDROXYPYRAZOLE ON ACTINOMYCIN D 
INHIBITION OF THE RNA POLYMERASE REACTION 
WHEN CALF THYMUS DNA WAS THE TEMPLATE 
UMP Incorporation 
System pmoles % Control 
Complete 238.41 100.00 
Plus Hydroxypyrazole 269.37 112.99 
Plus Actinomycin D 202.96 85.13 
Plus Hydroxypyrazole and Actinomycin D 151.92 63.72 
Minus RNA Polymerase 1.80 0.76 
Minus DNA 3.73 1.56 
*A 1:1 molar ratio (3.2 x lo-7 M) of the hydroxypyrazole and 
actinomycin D was used in this investigation in which the 
results were determined by the standard assay method. 
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Figure 19. Time-Course: Effect of the Hydroxypyrazole on 
Actinomycin D Inhibition of the RNA Polymerase 
Reaction when Calf Thymus DNA Was the Template. 
e 1 complete control; tt , hydroxypyrazole~ 
3.2 x lo-7 H; •, actinomycin D, 3.2 x 10-1M; 
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TABLE III 
EFFECT OF THE HYDROXYPYRAZOLE ON ACTINOMYCIN D 
INHIBITION OF THE RNA POLYMERASE 
WHEN P. FLUORESCENS DNA 
WAS THE TEMPLATE 
UMP Incorporation 
System pmoles % Control 
Complete 168.33 100.00 
Plus Hydroxypyrazole 186.27 110.66 
Plus Actinomycin D 146.63 87.11 
Plus Hydroxypyrazole and Actinomycin D 116.91 69.45 
Minus RNA Polymerase 0.92 0.55 
Minus DNA 2.49 1.48 
* A 1:1 molar ratio (3. 2 x lo-7 M) of the hydroxypyrazole and 
actinomycin D was used in this investigation in which the 
results were determined by the standard assay method. 
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gfect of the Hydroxypyrazole on 
Actinomycin D Inhibition of RNA 
Chain Elongatiop 
103 
In order to study the effect of the hydroxypyrazole on 
actinomycin D inhibition of RNA chain elongation, experiments 
were performed using the high salt method of Hyman and 
Davidson (1970). Under these conditions 1 the 1:1 molar ratio 
(3o2 x lo-7 M) of the hydroxypyrazole and actinomycin D 
inhibited RNA chain elongation by an amount which was more 
than 15% greater than the actinomycin D control (Table IV). 
This suggests that the maj:or effect of the hydroxypyrazole 
on actinomycin D action is at the level of RNA chain elonga-
tion. Of importance; is the observation that the hydroxy-
pyrazole control exhibited no stimulation. Thus, the 
hydroxypyrazole most likely stimulates RNA synthesis by 
affecting template site selection and activation by the RNA 
polymerase holoenzymeo 
Effects of Time-Course Addition on the 
Increase in Actinomycin D Inhibition 
of the RNA PolY}I!Brase Reaction 
· by the Hydroxypyrazole 
Time-course addition of the hydroxypyrazole and actino-
mycin D was investigated to determine if the hydroxypyrazole 
acts alone to increase actinomycin D inhibition of the RNA 
polymerase reaction, or if the proposed complex of the hy-
droxypyrazole and actinomycin D is responsible for this 
System 
TABLE IV 
EFFECT OF THE HYDROXYPYRAZOLE ON ACTINOMYCIN D 
INHIBITION OF RNA CHAIN ELONGATION 
WHEN CALF THYMUS DNA 
WAS THE TEMPLATE 
UMP Incorporation 
pmoles % Control 
Complete 89.77 100.00 
Plus Hydroxypyrazole 90.89 101.25 
Plus Actinomycin D 74.95 83.49 
Plus Hydroxypyrazole and Actinomycin D 61.27 68.25 
Minus RNA Polymerase 1.15 1.28 
Minus DNA 0.83 0.92 
*A 1:1 molar ratio (3.2 x lo-7 M) of the hydroxypyrazole and 
actinomycin D was used in this investigation in which the 
results were determined by the RNA chain elongation assay. 
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action. The results reveal that the inhibition of actinomy-
cin D was increased the greatest when the hydroxypyrazole 
was added first to the reaction mixture (Table V)., When the 
actinomycin D was added first, a significant but slightly 
smaller increase was observed" Quite surprisingly, a 1:1 
molar ratio (3 0 2 x lQ-7 M) which had been preincubated for 
15 minutes at 37 C failed to inhibit RNA synthesis when this 
mixture was added inunediately beforeCTP was added to start 
the reaction. However, if this preincubated mixture was 
added to the reaction mixture and incubation was continued 
for another 15 minutes at 37 C before CTP was added to start 
the reaction. an increase in inhibition was observed which 
was comparable to the increase demonstrated by the addition 
of the hydroxypyrazole first., Therefore, it appears that 
the action of the proposed hydroxypyrazole:actinomycin D 
complex, which is readily formed in an aqueous environment, 
may not be completely responsible for the increase observed 
in actinomycin D inhibition of the RNA polymerase reaction. 
Two alternatives may be used to explain this. One possibi-
lity is that conformational changes may be required in the 
hydroxypyrazole:actinomycin D complex or the DNA before the 
hydroxypyrazole:actinomycin D complex can successfully .bind 
to the DNA and inhibit RNA synthesis. For example, the 
unreduced quinoidal phenoxazone ring system of actinomycin D 
has an integral role in both the DNA:actinomycin D and 
hydroxypyrazole:actinomycin D models as they are presently 
depictedo Thus, it is reasonable to assume that some 
TABLE V 
EFFECTS OF TIME-COURSE ADDITION ON THE INCREASE 
IN ACTINOMYCIN D INHIBITION OF THE RNA 






Plus Actinomycin D 
Plus Hydroxypyrazole and Actinomycin D 
Added Simultaneously 
Plus Hydroxypyrazole; Actinomycin D 
Added After Incubation for 
15 Minutes at 37 C 
Plus Actinomycin D; Hydroxypyrazole 
Added After Incubation for 
15 Minutes at 37 C 
Plus Hydroxypyrazole and Actinomycin D 
Which Have Been Preincubated for 
15 Minutes at 37 C and Added just 
Prior to CTP 
Plus Hydroxypyrazole and Actinomycin D 
Which Have Been Preincubated for 
15 Minutes at 37 C 
Minus RNA Polymerase 
Minus DNA 
Minus CTP 












*A 1:1 molar ratio (3.2 x lo-7 M) of the hydroxypyrazole and 
actinomycin D was used in this investigation in which the 
results were determined by the time-course addition assay. 
** Calf thymus DNA was used as the template. 
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conformational changes may be required before the hydroxypy-
razole:actinomycin D complex effectively binds to DNA and 
inhibits RNA synthesis. In the second possibility, the 
hydroxypyrazole may bind to DNA in such a manner that subtle 
conformational changes are introduced in the DNA helix which 
alloW's actinomycin D to bind more efficiently., Regardless 
of the mechanisms employed, both alternatives may involve 
the binding of actinomycin D at secondary sites which nor-
mally bind actinomycin D only weakly. Several reports have 
noted the existence of at least two types of binding sites 
for actinomycin D, one of which has a binding constant that 
is many times greater tqan the other (Cavalier and Nemchin, 
1964; Wells and Larson, 1970; Hyman and Davidson, 1971). 
The distinction between these sites is thought to depend 
on the helical structure of the DNA. 
More recently. Krugh and Young (1977) reported that two 
intercalating agents, daunomycin and adriamycin, coopera-
tively facilitate the binding of actinomycin D to poly-d(A-T)· 
poly-d(A-T)., Since actinomycin D does not normally bind to 
this double-stranded polynucleotide, the results of this 
investigation demonstrated that when daunomycin or adriamycin 
bind to poly-d(A-T)·poly-d(A-T), a change occurs in the con-
formation of the polynucleotide which results in an increase 
in the stability of the poly-d(A-T)apoly-d(A-T):actinomycin 
D complex. 
The second alternative may also account for the stimula-
tory effect which was observed for the hydroxypyrazole., 
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Richardson (1966) reported that there are two kinds of asso-
ciation between P~A polymerase and the DNA. There is an 
interaction with a high binding affinity that keeps the 
enzyme bound to the DNA even though the concentration of free 
enzyme is very low, and there is an interaction with a much 
lower affinity that requires very high concentrations of 
free enzyme~ If the hydroxypyrazole does produce conforma-
tional changes in the DNA helix, it would be logical to 
assume that the binding of RNA polymerase may be affected. 
Effect of Protocatechuate on the 
Actinomycin D Inhibition of the 
RNA Polymerase Reaction 
Data obtained utilizing the standard assay method re-
vealed that 1:1 molar ratios (1. 3 x lo-6 M) of protocatechuate 
and actinomycin D prevented actinomycin D inhibition of RNA 
synthesis by nearly 31%, as compared to the complete control 
when calf thymus DNA was the template (Table VI). Protoca-
techuate had no effect on RNA synthesis at this concentration. 
A time-course experiment demonstrated that protocatechuate 
began to alleviate actinomycin D inhibition shortly after 
the first few minutes of the reaction (Figure 20). Compara-
ble results were obtained when P. fluorescens DNA was used 
as the template (Table VII). 
TABLE VI 
EFFECT OF PROTOCATECHUATE ON THE ACTINOMYCIN D 
INHIBITION OF THE RNA POLYMERASE REACTION 
WHEN CALF THYMUS DNA WAS 
THE TEMPLATE 
UMP Incorporation 
System pmoles % Control 
Complete 229.24 100.00 
Plus Protocatechuate 227.33 
Plus Actinomycin D 83.76 
Plus Protocatechuate· and Actinomycin D 154.87 
Minus RNA Polymerase 1.26 
Minus DNA 3.15 
*A l:l.molar ratio (1.3 x lo-6 M) of protocatechuate and 
actinomycin D was used in this investigation in wh:lch the 







·Figure 20o Time-Course: Effect of Protocatechuate on the 
Actinomycin D Inhibition of the RNA Polymerase 
Reaction when Calf Thymus DNA ~~ras the Template. 
e 1 complete control and protocatechuate (1.3 
x 10-6 H); 8 t acti!f.omycin D (1. 3 x lo-6 M) ; 
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TABLE VII 
EFFECT OF PROTOCATECHUATE ON THE ACTINOMYCIN D 
INHIBITION OF THE RNA POLYMERASE 
REACTION WHEN P. FLUORESCENS DNA 
WAS THE TEMPLATE 
UMP Incorporation 
Sys·tem pmoles % Control 
Complete 176.73 100.00 
Plus Protocatechuate 177.88 100.66 
Plus Actinomycin D 69.35 39.24 
Plus Protocatechuate and Actinomycin D 117.30 66.37 
Minus RNA Polymerase 0.83 0.47 
Minus DNA 2.24 1.27 
*A 1:1 molar ratio (1.3 x 10-6M) of protocatechuate and 
actinomycin D was used in this investigation in which the 
results were determined by the standard assay method. 
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Effects of Time-Course Addition on the 
Decrease in Actinomvcin D Inhibition of . . 
the RNA Polymerase Reaction 
by Protocatechuate 
113 
Time-course addition of protocatechuate and actinomycin 
D was performed to determine if protocatechuate could reverse 
actinomycin D inhibition of RNA synthesis, in addition to its 
ability to partially prevent this inhibition. The results 
of this investigation revealed that a 1:1 molar ratio (1. 3 
X ro-6 11) of protocatechuate. and actinomycin D which had 
been preincubated for 15 minutes at 37 C prevented actinomy-
cin D inhibition of RNA-synthesis by the greatest amount 
(Table VIII). vfuen either ~rotocatechuate or actinomycin D 
was added to the reaction mixture and incubated for 15 min-
utes at 37 C before the second compound and CTP were added 
to start the reaction, the inhibition which was observed 
was almost identical to the actinomycin D control. This 
suggests that protocatechuate, which binds to DNA (Blunk, 
1977), is not readily available for interaction with the 
actinomycin D. However, if protocatechuate was added to 
the reaction mixture and incubation was continued for an 
additional 15 minutes at 37 C before CTP was added to start 
the reaction, a significant decrease in actinomycin D inhi-
bition was demonstrated. Thus, the alleviation of actino-
mycin D inhibition of RNA synthesis by protocatechuate is a 
consequence of molecular interaction between these compounds. 
Both the prevention and reversal may be explained if the 
TABLE VIII 
EFFECTS OF TIME-COURSE ADDITION ON THE DECREASE 
IN ACTINOMYCIN D INHIBITION OF THE RNA 






Plus Actinomycin D 
Plus Protocatechuate and Actinomycin D 
Added Simultaneously 
Plus Protocatechuate and Actinomycin D 
Which Have Been Preincubated for 
15 Minutes at 37 C 
Plus Protocatechuate; Actinomycin D 
Added After Incubation for 15 
Minutes at 37 C 
Plus Actinomycin D; Protocatechuate 
Added After Incubation for 
15 Minutes at 37 C 
Complete II 
Plus Actinomycin D; Protocatechuate 
Is Added and Another Incubation 
for 15 Minutes at 37 C Is Carried 
Out Before CTP Is Added 
Minus RNA Polymerase 
~nus DNA 
Minus CTP 












23.91 7. 77 
*A 1:1 molar ratio (1.3 x 10-6M) of protocatechuate and 
actinomycin D was used in this investigation in which the 
results were determined by the time-course addition assay. 
** Calf thymus DNA was used as the template. 
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equilibrium favors the protocatechuate:actinomycin D species 
rather than the DNA:actinomycin D complex. Because the bind-
ing of actinomycin D to DNA is reversible, protocatechuate 
may be interacting solely with unbound actinomycin D, or 
perhaps, protocatechuate may function to facilitate there-
lease of actinomycin D from the DNA. 
Influence of the Hydroxypyrazole 
on Membrane Permeability 
Effect of _Surface-A!=!tive Agents 
on Actinomycin D Inhibition 
of P<> fluorescens 
Haslam (1973) demonstrated that the hydroxypyrazole 
exhibited subtle membrane action against sheep red blood 
cells and B. subtilis 't-J23 protoplasts. Further investiga-
tion revealed that the hydroxypyrazole potentiated the in-
hibition produced by two membrane active antibiotics, 
polymyxin and circulin, against P. fluorescens. Because 
previous investigation in this laboratory has revealed 
that the hydroxypyrazole may also have a site of action at 
the membrane, experiments were conducted with selected 
surface-active agents to compare increases in actinomycin 
D action produced by these compounds with the increase 
resulting from the hydroxypyrazole,. 
Triton X-100, Tween 80, 1-hexadecylpyridinium chloride 
and SDS were tested to determine if non-inhibitory concen-
trations of these compounds could increase the action of 
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.actinomycin D against P. fluorescens. No increases in acti-
nomycin D action were observed with either the non-ionic 
detergents, Triton X-100 and Tween 80, or the anionic deter-
gent, SDS. Only cells treated with the cationic detergent, 
1-hexadecylpyridinium chloride, exhibited moderate increases 
in susceptibility to actinomycin D (Table IX)o The inability 
of the 1-hexadecylpyridinium chloride to produce large in-
creases in actinomycin D inhibition provides added support 
that the hydroxypyrazole does not increase actinomycin D 
inhibition solely by its action on the membrane. For example, 
the hydroxypyrazole increases the inhibition of actinomycin 
D at a concentration of 3.2 x lo-6 M by approximately 70%. 
The prevention of actino.mycin D inhibitio.n in both the 
1-hexadecylpyridinium chloride treated and untreated cells 
by protocatechuate further demonstrates that molecular inter-
action between protocatechuate and actinomycin D may be re-
sponsible for this compounds action. 
Effect of the Hydroxypyrazole 
and Actinomycin D on Uptake of 
Labeled Substrates 
Uptake experiments with P~ fluorescens were performed 
to measure the capacity of the hydroxypyrazole, actinomycin 
D, or combinations of·these compounds to affect uptake of 
selected substrates. The substrates included 14c-2,3-suc-
cinate, D-14c-l-alanine, DL-14c-3-phenylalanine, DL-14c-3-
aspartate and 14c-2-uracil. Only the uptake of DL-aspartate 
TABLE IX 
EFFECT OF 1-HEXADECYLPYRIDINIUM CHLORIDE ON 
ACTINOMYCIN D INHIBITION OF P. FLUORESCENS 
AND PREVENTION OF THIS INHIBITION 
BY PROTOCATECHUATE 
Concentration of Compounds (Molarity) 
1-Hexadecylpyridinium 
Actinomycin D Protocatechuate Chloride 
3.2 X 10-6 0.0 0.0 
8.0 X 10-6 0.0 0.0 
0.0 6.5 x lo-4 0.0 
0.0 0.0 1.0 x lo-5 
3.2 X 10-6 0.0 1.0 x lo-5 
8.0 x 1o-6 0.0 1.0 X 10-5 
3.2 X 10-6 6.5 x lo-4 0.0 
8.0 X 10-6 6.5 x lo-4 0.0 
3.2 X 10-6 6.5 x lo-4 l.Ox lo-5 
8.0 X 10-6 6.5 x lo-4 l.Ox 10-5 

















was affected by any of the concentrations or combinations of 
the hydroxypyrazole and actinomycin D. Even so, the uptake 
of DL-aspartate was only slightly affected by the hydroxypy-
razole arid not at all by actinomycin D (Table X), Combina-
tions of the hydroxypyrazole and actinomycin D inhibited 
DL-aspartate uptake to the same degree as the hydroxypyrazole, 
These results indicate that the proposed hydroxypyrazole: 
actinomycin D complex apparently does not alter membrane 
permeability of these substrates; and that the hydroxypyra-
zole inhibition of uptake is not comprehensive. This sub-
stantiates earlier reports that the hydroxypyrazole action 
at the membrane is slight. 
Effect of the Hyd~?XYEYrazole and 
A,ctinomy:cin D on Membrane Permeability 
of Reconstituted Outer Membrane Vesicles 
The outer membrane of several Gram-negative bacteria 
constitutes a permeability barrier which allows only hydro-
philic molecules below a given molecular weight to passively 
diffuse through the membrane. Outer membrane exclusion 
limits of 550-650 daltons have been reported for the enteric 
bacteria E.· coli K-12 and B, Salmonella typhimurium, Proteus 
mirabilis and Proteus mor~anii (Nakae and Nikaido, 1975; 
Decad and Nikaido, 1976; Nixdorf£ et al., 1977). Outer mem-
brane proteins, which have been named porins, have been 
demonstrated to be responsible for these exclusion limits, 
These porins are reported to have molecular weights between 
TABLE X 
EFFECT OF THE HYDROXYPYRAZOLE AND ACTINOMYCIN D 
ON UPTAKE OF Dt-14c-3-ASPARTATE 
BY P. FLUORESCENS 
Concentration of Compounds CPM/mg Cell Dry Weight x lo-3 
(Molarity) 
Actinomycin D Hydroxypyrazole 1 min 2 min 3·min 5 min 
0.0 0.0 4.41 7.69 13.60 26.34 
3.2 x 1o-6 0.0 4.47 8.07 13.16 27.23 
0.0 3.2 x 1o-6 4.37 8.23 13.44 28.87 
0.0 4.2 x lo-5 4.28 7.45 12.73 21.48 
3.2 X 10-6 3.2 x 10-6 4.59· 8.11 14.25 27.54 









35,000 to 40,000 daltons. In contrast to the enterics, 
Hancock et al. (1979) reported that the exclusion limit of 
P. aeru&inosa was in the order of 6000 ± 3000 daltons; and 
that a major outer membrane polypeptide of approximately 
35,000 daltons was responsible for the size-dependent per-
meability of the outer membrane in this bacterium. 
Vesicles reconstituted from outer membrane components 
(including phospholipids, LPS and proteins) provide useful 
systems for detecting small changes in membrane permeability. 
Outer membrane components of P. fluorescens were isolated, 
purified and reconstituted into vesicles to further inves-
tigate any action which the hydroxypyrazole, or combinations 
of the hydroxypyrazole and actinomycin D may exert on mem-
brane permeability. 
gualitative Analxsis of Isolated PhospholiE,ids from 
P, fluorescens. Phospholipids from P. fluorescens -.;v-ere pre-
pared by the method of Folch et al. (1957). The two major 
phospholipids of P, fluorescens, phosphatidylethanolamine 
and phosphatidylglycerol, were conclusively identified by 
thin layer chromatography with known standards (Table XI). 
Detection was accomplished with the appropriate spray re-
agent. In addition to the phospholipids, two lipid contain-
ing compounds were included in the phospholipid preparation 
which were not identified. 
Outer Hembrane Protein Isolation and Purification. 




Phos ph a tidy 1- 0.563 
ethanolamine 
Unknown o. 906 
Unknown 0.969 
TABLE XI 
QUALITATIVE ANALYSIS OF ISOLATED 
PHOSPHOLIPIDS FROM P. 
FLUORESCENS 
FeCl3-Salicyl-
Rhodamine sulphonic Acid Ninhydrin 
+ + 










of Hancock and Nikaido (1978). After two passages through 
a French pressure cell at 15,000 pounds per square inch, the 
disrupted cells were treated with deoxyribonuclease I, ribo-
nuclease I and lysozyme. Cell debris was removed by low 
speed centrifugation, and the supernatant was decanted, di-
luted and layered onto sucrose gradients containing steps of 
70 and 15% (w/v) sucrose in Tris-HCl bufferg These tubes 
were centrifuged at 4 C and 183,000 x g for 1 hour in a 
Beckman SH 41 rotor. The bottom 2 ml of each gradient was 
removed, pooled, diluted and applied to sucrose density gra-
clients containing steps of 70, 64, 58 and 52% (w/v) sucrose 
in Tris-HCl buffer. These tubes were centrifuged at 4 C and 
96,000 x g for 18 hours in a Beckman SW 27 rotor. The four 
bands which were observed (Figure 21) were removed by drop-
wise collection from the bottom of the centrifuge tube and 
assayed for succinate dehydrogenase, KDO, lipid phosphate 
and protein. 
The results of the analysis of the four bands are shown 
in Table XII. Comparison of the relative amounts of succi-
. 
nate dehydrogenase and KDO contained in bands I and IV re-
vealed that these bands consist of purified outer and inner 
membranes, respectively. The two most dense bands (I and II) 
were enriched with outer membrane components while the least 
dense band (IV) was purified inner membrane. Band II con-
tained a small amount of the inner membrane marker, succinate 
dehydrogenase, while band III contained a slightly larger 
amount of this enzyme. Both these bands contained moderate 
·Figure 21. Relative Running Positions of the Four Visible 
Bands from the Second Sucrose Density Gradient. 
The size of the bands is represented by the 
width while the amount of protein is repre-
sented by the height of the bars. 
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RELATIVE RUNNING POSITION 
124 
TABLE XII 
ANALYSIS OF THE OUTER MEMBRANE FRACTIONS 
% of Protein SDH 
Fraction Recovered Activity* KDO** Lipid Phosphate*** 
I 12.3 10.24 213.37 0.203 
II 36.5 27.45 59.14 0.393 
III 23.9 50.51 93.75 o. 717 
IV 27.3 162.04 3.81 0.290 
* SDH, Succinate dehydrogenase; Activity is expressed as 
micromoles of dichloroindolephenol reduced per 
minute per milligram of protein. 
** KDO, 2-keto-3-deoxyoctonate; Amount is expressed as 
nanomoles per milligram of protein. 




amounts of LPS. Band III contained both inner and outer 
membrane markers. 
Outer membrane proteins were fractionated by the method 
of Hancock et al. (1979). The lower two bands ,..vere pooled, 
diluted with sterile deionized water and centrifuged at 4 C 
and 177,000 x g for 1 hour in a Beckman SW 41 rotoro As 
described, the resulting pellet was solubilized in Tris-HCl 
buffer containing 2% Triton X-100 and Triton X-100 insoluble 
protein was sedimented by ultracentrifugation. This Triton 
X-100 insoluble protein was then solubilized in Tris-HCl 
buffer containing 2% Triton X-100 and 10 mH EDTA. Triton 
X-100/EDTA insoluble protein was removed by ultracentrifuga-
tion and the supernatant containi11g Triton X-100/EDTA soluble 
outer membrane proteins was applied to a DEAE-Sephacel col-
umn. The proteins were eluted from the column with a sodium 
chloride concentration gradient (0.1 to 0.6 M) and fractions 
(7 ml) were collected and analy~ed for protein content by 
the method of Lowry et al. (1951) (Figure 22). Appropriate 
fractions were pooled and concentrated to about 3-5 ml by 
dialysis in polyethylene glycol. Triton X-100 was removed 
from the protein samples with Bio-Gel SM-2 copolymer beads by 
by the method of Holloway (1973). This treatment removed 
Triton X-100 to a sufficiently low level (less than 0.05%) 
such that vesicle reconstitution was not affectedo After 
Triton X-100 removal, the protein fractions were divided 
into 0.5 ml aliquots and stored at -20 C. 
Figure 22. Elution of Outer Hembrane Proteins from DEAE-
Sephacel. e e , protein. 
l{) 
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SDS Polxacrylamfde Gel' Electrophoresis of Outer Membrane 
Proteins. SDS polyacrylamide gel electrophoresis of the 
pooled column fractions was performed by the method of Lug-
tenberg et al, (1975) to locate fractions containing outer 
membrane proteins having molecular weights of approximately 
35,000 daltons. These gels were compared to gels of Triton 
X-100/EDTA soluble protein (which was loaded onto the column), 
Triton X-100/EDTA insoluble protein, Triton X-100 soluble 
protein and molecular weight standards (Figure 23). 
Hancock and Nikaido (1978) reported that the outer mem-
brane of P, aerusinosa PAOl contained four major outer mem-
brane proteins having molecular weights of 17, 21, 35 and 
37 K. The Triton X-100 soluble protein contained no signi-
ficant amounts of any of the major outer membrane proteins. 
The Triton X-100/EDTA insoluble material contained signifi-
cant amounts of the 17, 35 and 37 K proteins while the 
Triton X-100/EDTA soluble fraction contained these three 
proteins plus the 21 K protein. However, in both the Triton 
X-100/EDTA soluble and insoluble fractions, the 35 K protein 
appeared as two closely spaced bands. Whether this repre-
sents two very similar proteins or a partial breakdown of 
the 35 K protein is not known, since this pattern was ob-
served in three separate outer membrane preparations. In 
addition, the Triton X-100/EDTA soluble material contained 
substantial amounts of two other proteins between the approx-
imate molecular weights of 30 to 33 K. Comparison with the 
report by Hancock et al. · (1979), indicates that these 
Figure 23. SDS Polyacrylamide Gel Electrophoresis of Outer 
Hembrane Proteins. A, protein standards: 
ovalbumin (45 K) 1 pepsin (34. 7 K), trypsinogen 
(24 K)- and lysozyme (14.,3 K), 1 p.g of each; 
B, Triton X-100/EDTA soluble proteins (20 J.lg); 
C, Triton X-100/EDTA insoluble proteins (20 
}lg): D; Triton x ... lQO soluble proteins (20 J.lg); 
·E, fractions 65-66 from DEAE-Sephacel column 






proteins remained in the Triton X-100/EDTA insoluble mater-
ial in their preparations. Despite these differences, the 
Triton X-100 soluble fraction contained substantial amounts 
of the four major outer membrane proteins which were pre-
viously reported for P, aeruginosa PAOl. 
SDS electrophoresis of the column fractions revealed that 
fractions 65-66 contained substantial amounts of only those 
proteins between the molecular weights of 33-37 K. The gel 
from this fraction demonstrated a complete separation of the 
protein bands at approximately 35 K. 
Effect of theHydroxypyrazole and Actinomycin Don 
MembranePerme<3,bility: of Reconstituted Outer Vesicles from 
P. fluorescens. Outer membrane vesicles were reconstituted 
from outer membrane components of P. fluorescens by the 
technique of Hancock and Nikaido (1978). Electron micro-
scopy was used to observe vesicles reconstituted from P. 
fluorescens phospholipids arid LPS (Figure 24). Spherical 
vesicular structures were clearly demonstrated in all vesicle 
preparationso 
Vesicles reconstituted· from phospholipids and LPS, with 
or without outer membrane proteins, were used to investigate 
the effect of the hydroxypyrazole, actinomycin D, or combi-
nations of these compounds on retention of 14c-sucrose within 
closed vesicles. ~~en vesicles reconstituted from phospho-
l~pids and LPS were exposed to the hydroxypyrazole for 20 
minutes at 25 C, a slight decrease in 14c-sucrose retention 
was demonstrated (Table XIII). However. the hydroxypyrazole 
Figure 24o Electron Micrograph of Vesicles Reconstituted 
from: P. fluorescens Phospholipids and LPS. 
The vesicle preparation was placed on a Formvar 
grid and negatively stained with uranyl acetate 
for 30-45 seconds. A, magnification; 76,000 






EFFECT OF THE HYDROXYPYRAZOLE ON THE 




(Molarity) Components* % 14c-Sucrose Retained 
0.0 PL, LPS 1.644 
2.1 X 1o-s PL, LPS 1.542 
4.2 X 10-5 PL, LPS 1.411 
8.5 x lo-5 PL, LPS 1. 396 
* PL, phospholipid; LPS, lipopolysaccharide. 
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did not appear to perturb the vesicle components to any great 
extent since most of the 14c-sucrose was still retained 
within the vesicles, Vesicles containing phospholipids, LPS 
and outer membrane proteins (either Triton X-100/EDTA soluble 
proteins or proteins from fractions 65-66) were not signifi-
cantly affected by the hydroxypyrazole, actinomycin D, or 
combinations of these compounds (Table XIV). Apparently 
the proteins stabilize the phospholipid arid LPS components 
of the vesicular membrane and negate the subtle effect of 
the hydroxypyrazole on these components. These results de-
monstrate that the hydroxypyrazole or the combination of the 
hydroxypyrazole and act~nomycin D does not influence the 
permeability functions of the outer membrane proteins because 
the amount of 14c-sucrose which diffused from the exposed 
vesicles was essentially the s.ame as the controls. This 
substantiates other data which has demonstrated that the 
effect of these compounds, alone or in combination, on mem-
brane permeability is very smallv 
It is important to note that vesicle preparations 
containing either Triton X-100/EDTA soluble proteins or pro-
teins from fractions 65-66 exhibited significant decreases 
in 14c-sucrose retention, as compared to vesicle preparations 
lacking outer membrane proteins, Therefore, both these 
protein· sources appeai;"ed to possess porin activity. 
TABLE XIV 
EFFECT OF THE HYDROXYPYRAZOLE AND 
ACTINOMYCIN D ON THE RETENTION OF 
14c-SUCROSE BY RECONSTITUTED 
OUTER MEMBRANE VESICLES 
Compounds (Molarity) 
Actinomycin D Hydroxypyrazo1e Components* 
0.0 0.0 PL,LPS 
0.0 4.2 x lo-5 PL,LPS 
3.2 x 1o-6 o.o PL,LPS 
3.2 x 10-6 4.2 x 10-5 PL,LPS 
0.0 0.0 PL,LPS,PRl 
o.o 4.2 x 1o-5 PL,LPS,PRl 
3.2 x 10-6 0.0 PL,LPS,PRl 
3.2 x 10-6 4.2 x 10-5 PL,LPS,PRl 
0.0 0.0 PL,LPS,PR2 
o.o 4.2 x lo-5 PL,LPS,PR2 
3.2 x 1o-6 o.o PL,LPS,PR2 















* PL, phospholipid; LPS, lipopolysaccharide; PRl, Triton 




The inhibition of P, fluorescens by actinomycin D was 
greatly increased when a non-inhibitory concentration of the 
hydroxypyrazole was added in combination to the medium. De-
creases in viable cell number and alterations in cell size 
were demonstrated which were customarily observed only for 
cells treated with highe·r concentrations of the antibiotic. 
Furthermore, the inhibition of cells exposed for 10 hours to 
the combination of the hydroxypyrazole and actinomycin D was 
bactericidal, although this concentration of actinomycin D 
was bacteriostatic when administered alone. Since actinomy-
cin D inhibition of ~· fluorescens is concentration depen-
dent; these results suggest that the hydroxypyrazole either 
facilitates entry of the antibiotic into the cell, or its 
ability to inhibit once it reaches a site of action within 
the cell. Investigations have revealed that exposure of 
growing cultures to the hydroxypyrazole was not sufficient 
to increase actinomycin D inhibition if the cells were 
washed and resuspended in fresh medium containing actinomy-
cin Do This suggests that both the hydroxypyrazole and 
actinomycin D must be present and act together, possibly 




Protocatechuate prevents and reverses the inhibition of 
P. fluorescens by actinomycin D without interfering with its 
diffusion into the cell (Durham and Keudell, 1969). Results 
have demonstrated that protocatechuate also prevents and re-
verses the increased inhibition which was observed when the 
hydroxypyrazole and actinomycin D were added in combination 
to the medium, The manner in which protocatechuate relieves 
this inhibition appears similar to the alleviation of inhi-
bition resulting from only actinomycin D. These data augment 
previous investigations and provide further support that 
molecular complexations may have an important role in the 
mechanism(s) which may ~e involved. 
The amidase system of Po fluorescens provided a more 
sensitive and direct method for determining changes in acti-
nomycin D action since inhibition of amidase synthesis by 
actinomycin D is also concentration dependent. At actinomy-
cin D concentrations which were 10 fold less than those used 
.. 
for growth studies, significant increases in actinomycin D 
inhibition of amidase synthesis were observed when the hy-
droxypyrazole was added in combination to the medium. Inac-
tivation of the amidase we.s eliminated since none of the 
concentrations or combinations of the hydroxypyrazole and 
actinomycin D produced any changes in amidase activity when 
in vitro experiments were performed with purified amidaseo 
Protocatechuate readily prevents and reverses inhibition of 
amidase synthesis by actinomycin D or the combination of the 
hydroxypyrazole and actinomycin D. Because both the 
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hydroxypyrazole and protocatechuate function to modulate ac-
tinomycin D inhibition of amidase synthesis, these data 
suggest that both compounds may affect the binding of acti-
nomycin D to DNAo In view of the low concentration of 
actinomycin D used in combination with the hydroxypyrazole, 
this is particularly noteworthy. 
The IDJA polymerase reaction is the primary biological 
site of action for actinomycin D. For a given concentration 
of DNA, the actinomycin D inhibition of the RNA polymerase 
reaction was concentration dependent. Very small increases 
in actinomycin D concentration resulted in very large in-
creases in inhibition, This behavior was observed until 
approximately 70% inhibition was achieved. Then the degree 
of inhibition was only slightly increased with increasing 
concentrations of actinomycin D. 
Depending on the concentration, the hydroxypyrazole can 
both inhibit and stimulate the RNA polymerase reaction. The 
concentration which was necessary to establish inhibition 
was more than 10 fold greater than the corresponding con-
centration of actinomycin D. The maximum inhibition achieved 
by higher concentrations of the hydroxypyrazole was limited 
to 30-35%. Stimulation of RNA polymerase was observed when 
the concentration of the hydroxypyrazole was 10 fold less 
than the concentration required to establish inhibitiono 
The hydroxypyrazole probably stimulates RNA synthesis by 
affecting template site selection and activation by the 
RNA polymerase holoenzymeo A stimulation of this nature may 
involve low affinity binding sites which do not normally 
bind RNA polymerase effectively at low concentrations. 
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When this stimulatory concentration of the hydroxypyra-
zole was added in combination with a 1:1 molar ratio of 
actinomycin D, a significant increase in actinomycin D inhi-
bition of RNA synthesis was observed. The major effect of 
the hydroxypyrazole on actinomycin D inhibition of RNA syn-
thesis is at the level of RNA chain elongation. 
The role that the proposed hydroxypyrazole:actinomycin 
D plays in increasing actinomycin D inhibition of RNA syn-
thesis is uncertain. Conformational changes may be required 
in the complex or the D~A before the complex can effectively 
bind DNA and inhibit RNA synthesis. The hydroxypyrazole 
may bind to DNA and introduce subtle conformational changes 
in the DNA helix which allow actinomycin D to bind more 
efficiently. This alternative would help explain the stimu-
lation of RNA polymerase by the hydroxypyrazole. The in-
crease in actinomycin D inhibition of RNA synthesis by the 
hydroxypyrazole may involve the binding of actinomycin D 
at secondary sites which normally bind actinomycin D only 
weakly; regardless of the mechanism(s) utilized. 
Protocatechuate partially prevented and reversed the 
inhibition of RNA synthesis resulting from a 1:1 molar ratio 
of actinomycin D. This provides further support that the 
alleviation of actinomycin D inhibition by protocatechuate 
is a consequence of molecular interactions between these 
compounds. Both the prevention and reversal may be explained 
142 
if a protocatechuate:actinomycin D complex is favored over 
the DNA:actinomycin D complex. Protocatechuate may be in-
teracting solely with unbound actinomycin D or it may act to 
facilitate the release of actinomycin D from DNA. 
Little or no effect on membrane permeability was ob-
served with the hydroxypyrazole, actinomycin D, or combina-
tions of these compounds during this investigationo This 
substantiates the report by Haslam (1973) that hydroxypyra-
zole action at the membrane is subtle, 
A model depicting possible mechanisms by which the hy-
droxypyrazole and protocatechuate may influence actinomycin 
D action is shown in Figure 25o 
In the simplest mechanism, the hydroxypyrazole acts 
alone to increase diffusion of actinomycin D into the cell. 
This is the least likely alte~native because all investiga-
tions to date have revealed that membrane action by the 
hydroxypyrazole was minor, Furthermore, growth of cells in 
the presence of the hydroxypyrazole was not sufficient to 
increase actinomycin D action when the cells were washed and 
resuspended in medium containing actinomycin D. 
The hydroxypyrazole and actinomycin D may enter the cell 
separately. Once inside the cell, the two compounds may com-
plex before binding DNA or they may interact with the DNA 
individually. If the.,hydroxypyrazole binding to DNA intro-
duces changes in the DNA helix, actinomycin D binding may be 
facilitated resulting in an increase in inhibition, This 
would be consistent with the RNA polymerase data; it would 
Figure 25. Hodel Depicting Possible Hechanisms by Which the 
Rydroxypyrazole and Protocatechuate Hay Influ-
ence. Actinomycin D Action. ~ , DNA; • , 
actinomycin D; e , hydroxypyrazole; * , pro-
tocate.chuate a• , hydroxypyrazo le: actinomycin 
D corr~lex; ~ , conformational change in 
the hydroxypyrazole:actinomycin D complex or 
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explain both the increase in actinomycin D inhibition and 
the stimulation of RNA synthesis. Although this mode of 
entry cannot be ruled out, it also appears unlikely, since 
the cells grown in the presence of the hydroxypyrazole were 
not inhibited to a greater extent than control cells when 
both sets of cells were exposed to the antibiotic. A re-
verse of this situation yielded the same result when cells 
were grown in actinomycin D and then exposed to the hydroxy-
pyrazole. 
All data to date suggests that the hydroxypyrazole and 
actinomycin D must both be present and act together to in-
crease actinomycin D action. A molecular complex of the 
·two compounds, formed outside the cell; would explain most 
of the present data. The proposed hydroxypyrazole:actino-
mycin D complex may increase passage of these compounds into 
the cell, although it has not demonstrated any capacity for 
altering membrane permeability. A complex of the hydroxy-
pyrazole and actinomycin D may be responsible for the·in-
creases observed in actinomycin D action, provided the 
complex has a greater affinity for DNA than does actinomycin 
Do If secondary sites are involved, a hydroxypyrazole: 
actinomycin D complex may bind effectively to DNA at sites 
which bind actinomycin D only weakly. This model is con-
sistent with most of the present data. However, the RNA 
polymerase data indicated that conformational changes in the 
hydroxypyrazole:actinomycin D complex or the DNA may bene-
cessary before RNA synthesis is inhibited. 
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Protocatechuate prevents and reverses actinomycin D 
action without interfering 1.vith its entry into the cello 
Apparently, the ability of protocatechuate to alleviate in-
hibition produced by either actinomycin D or the combination 
of the hydroxypyrazole and actinomycin D is a consequence 
resulting from an interaction of protocatechuate with these 
compounds. In both cases, protocatechuate may be interacting 
with either the unbound molecules to decrease their affinity 
to bind DNA or with the bound molecules to facilitate their 
release from the DNA. 
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